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Abstract
The gastrointestinal tract has evolved in the context of continuous exposure to both commensal organisms as
well as dietary intake. While the impact of commensal organisms on the immune system has been well
studied, the effects of dietary factors in the control of intestinal immunity remain unclear. Moreover, the
immunologic effects of vitamin deficiencies and are poorly understood. Using a mouse model of dietary
vitamin A deficiency, we investigated mechanisms by which the principle vitamin A metabolite, retinoic acid,
regulates several aspects of innate immunity. In Chapter 1 we present the hypothesis that the homeostasis of
innate cells in the GI tract is dominantly regulated by dietary vitamin A. In Chapter 2 we explore both the
function of intestinal eosinophils in the GI tract and the role of vitamin A in supporting their unique intestinal
functionalities. Chapter 3 highlights the dependence of CD103+ dendritic cells on dietary vitamin A for their
homeostasis in the GI tract. As well, we find that CD103+ DCs require retinoic acid receptor alpha (RARa)
for their production of retinoic acid. In Chapter 4 we demonstrate that vitamin A regulates an inverse balance
between innate lymphoid cell (ILC) subsets by promoting IL-22 producing ILC3 while directly suppressing
IL-13 producing ILC2. Consequently, Vitamin A deficiency results in impaired immunity against bacterial
infection and a reciprocal increase in type 2 responses to worm infection. Chapter 5 presents a unified model
of gastrointestinal innate immunity during vitamin A deficiency and it implications for understanding
intestinal barrier defense during malnutrition as well as during normal immune homeostasis. Further, we
hypothesize that RA serves as a indicator of nutrient status and that RARa signaling may be required for most
immune cells to achieve full inflammatory/proliferative potential. Thus, ILC2 may be unique in their
metabolic requirements, allowing them to persist and function in states of nutrient deprivation. Thus, in
vitamin A deficiency, a switch to innate type 2 immunity may represent a powerful adaptation of the immune
system to promote host survival in the face of ongoing barrier challenges and the immune deficits discussed in
the previous chapters.
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ABSTRACT 
 
REGULATION OF INTESTINAL INNATE IMMUNITY BY DIETARY VITAMIN A 
Sean P. Spencer 
Mentor: Yasmine Belkaid 
The gastrointestinal tract has evolved in the context of continuous exposure to both 
commensal organisms as well as dietary intake.  While the impact of commensal 
organisms on the immune system has been well studied, the effects of dietary factors in 
the control of intestinal immunity remain unclear.  Moreover, the immunologic effects of 
vitamin deficiencies and are poorly understood.   Using a mouse model of dietary vitamin 
A deficiency, we investigated mechanisms by which the principle vitamin A metabolite, 
retinoic acid, regulates several aspects of innate immunity.  In Chapter 1 we present the 
hypothesis that the homeostasis of innate cells in the GI tract is dominantly regulated by 
dietary vitamin A.  In Chapter 2 we explore both the function of intestinal eosinophils in 
the GI tract and the role of vitamin A in supporting their unique intestinal functionalities.  
Chapter 3 highlights the dependence of CD103+ dendritic cells on dietary vitamin A for 
their homeostasis in the GI tract.  As well, we find that CD103+ DCs require retinoic acid 
receptor alpha (RARa) for their production of retinoic acid.  In Chapter 4 we 
demonstrate that vitamin A regulates an inverse balance between innate lymphoid cell 
(ILC) subsets by promoting IL-22 producing ILC3 while directly suppressing IL-13 
producing ILC2.  Consequently, Vitamin A deficiency results in impaired immunity 
against bacterial infection and a reciprocal increase in type 2 responses to worm 
infection. Chapter 5 presents a unified model of gastrointestinal innate immunity during 
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vitamin A deficiency and it implications for understanding intestinal barrier defense 
during malnutrition as well as during normal immune homeostasis.  Further, we 
hypothesize that RA serves as a indicator of nutrient status and that RARa signaling 
may be required for most immune cells to achieve full inflammatory/proliferative 
potential.  Thus, ILC2 may be unique in their metabolic requirements, allowing them to 
persist and function in states of nutrient deprivation.  Thus, in vitamin A deficiency, a 
switch to innate type 2 immunity may represent a powerful adaptation of the immune 
system to promote host survival in the face of ongoing barrier challenges and the 
immune deficits discussed in the previous chapters.   
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INTRODUCTION: INTESTINAL INNATE IMMUNE SYSTEM IS 
REGULATED BY DIETARY FACTORS 
	  
Intestinal Immune system faces unique challenges 
	  
Maintenance of barrier defense is an essential component of mammalian host health 
and survival.  Barrier sites of the body (skin, lung, gut and genital tract) are constitutively 
exposed to the external environment.  As such, each site houses a unique and complex 
commensal microflora that inhabits its epithelial surface1, 2, 3.  Amongst all barrier sites, 
the gastrointestinal (GI) tract is charged with a particularly difficult task: it must absorb 
nutrients while simultaneously establishing détente with commensal microflora and 
defending against invading pathogens. Critical to achieving this task is the immune 
network of the GI tract, which is home to one of the largest reservoirs of immune cells in 
the body4.    
The immunologic network of the GI tract is enriched in both innate and adaptive effector 
cell types that are specialized to maintain homeostasis in this complex environment.  
The innate compartment of the GI tract contains predominately dendritic cells (DCs), 
eosinophils, and innate lymphoid cells (ILCs) 5, 6, 7, 8.  The adaptive immune compartment 
of the GI tract contains a diverse array of both effector and regulatory T cells and IgA 
producing B cells9.  Both components of the immune system work in concert to promote 
barrier function of the GI tract and to maintain tolerance to food and commensal 
bacteria.  
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Our understanding of the intestinal immune system has grown immensely over the past 
decade. With this understanding has come a greater appreciation of the dominant 
signals immune cells are exposed to in the GI tract: 1) commensal organisms and 2) 
dietary derived factors.   The human intestinal tract contains 100 trillion microbial cells 
and there is now strong evidence that the commensal microbiota influence both innate 
and adaptive immunity.  Mice lacking commensal microbes have impaired effector T cell 
development in the GI tract that can be partially restored with the provision of a single 
bacterial group, the segmented filamentous bacteria (SFB)10.  Commensal bacteria can 
also confer regulatory properties via the secretion of molecules that promote regulatory 
T cell function and restrain neutrophil activation 11, 12, 13.   
In addition to tonic commensal microflora derived signals, the GI tract is uniquely 
positioned for tonic exposure to dietary intake.  Either directly or via its processing by 
commensal communities, dietary intake provides a multitude of metabolites with the 
potential to influence immune function.  As well, the intestinal immune system appears to 
be uniquely well equipped to respond to dietary derived factors and micronutrients and, 
in some cases, relies on these nutritional cues for its function14.  For example, the 
immune system can directly sense dietary aryl hydrocarbon receptor (AHR) ligands 
present in cruciferous vegetables.  Metabolites of the plant derived phytochemical 
indole-3-carbinol (I3C) are recognized by the transcription factor AHR to promote intra-
epithelial lymphocyte development as well as lymphoid tissue development via its effects 
on innate lymphoid cell survival and proliferation 15, 16, 17, 18, 19.   
The most well studied dietary components with direct effects on the immune system are 
essential dietary micronutrients, Vitamin A, B and D20.   One dietary micronutrient that 
has emerged as a critical mediator of immune responses is Vitamin A and, particularly, 
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its metabolite retinoic acid (RA)21.  Indeed, vitamin A has long been recognized to have 
important roles in the support of systemic immunity20 and the severe health effects of 
vitamin A deficiency underscore the importance of this micronutrient in the promotion of 
immunity. Vitamin A deficiency, one of the most common micronutrient deficiencies22, is 
associated with higher incidence of and mortality from diarrheal disease23, while 
supplementation of deficient children with Vitamin A is able to reduce mortality24.  
Although the importance of Vitamin A in supporting mucosal immunity has long been 
appreciated, recent findings have enhanced our understanding of the diverse 
mechanisms by which Vitamin A accomplishes this task and its contextual role in 
promoting immunity.  
Vitamin A: A keystone dietary micronutrient for intestinal immunity  
	  
Vitamin A is a fat-soluble essential micronutrient obtained from foods containing either 
vitamin A precursors in the form of carotenoids or from vitamin A itself in the form of 
retinyl esters 25. After absorption, retinyl esters are hydrolyzed into retinol in the liver for 
release into the circulation or are recycled into the gut via bile drainage. Retinol taken up 
by cells is converted to retinoic acid (RA) by sequential oxidation by alcohol 
dehydrogenases (ADH) and retinaldehyde dehydrogenases (RALDH). RA is mainly 
generated in the all-trans isoform25 and, therefore, the effects of this compound are the 
focus of current research efforts.   
Retinoic acid serves as an important cue for cell differentiation during embryogenesis 
and neural development across all vertebrate species26.   In adult life, RA continues to 
serve as a key signal in the control of epithelial cell differentiation and in immune 
homeostasis. RA acts mainly by binding to three type II nuclear receptors: Retinoic Acid 
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Receptor alpha, beta and gamma (RARα, RARβ, RARγ)27.    With their binding partners, 
the Retinoid X receptors (RXRα, RXRβ, RXRγ), RARs bind directly to DNA and either 
activate or repress gene expression depending on the recruitment of co-activator or co-
repressor complexes.  
Although RA is constitutively present in serum at low levels 28, RALDH induction is 
subject to tight regulation and is controlled by environmental cues. Many cell types in the 
intestine are capable of synthesizing RA, including epithelial, stromal and dendritic cells. 
An important source of RA in the lamina propria of the intestine is thought to arise from a 
specialized subset of CD103+ migratory DCs with high basal expression of Aldh1a2, 
encoding the enzyme responsible for RA generation, RALDH2 29, 30, 31. Initial reports 
indicated that RA expression could be driven by the cytokines GM-CSF and IL-4 32. 
Subsequently, TLR signaling was shown to promote RALDH2 expression in both 
mucosal and peripheral DCs 33.  Interestingly, RA itself has been shown to re-enforce 
RALDH2 expression in DCs 33, 34.  These data suggest a model in which gut specific 
factors (cytokines, TLR ligands, or RA) prime DCs to generate RA, which is then sensed 
by DCs in order to re-enforce RA production. 
Retinoic acid (RA) came into focus as an important factor for promoting intestinal 
immunity when it was found to directly induce the gut homing markers α4β7 and CCR9 
on both T cells and B cells 31, 35. These studies highlighted the importance of RA in 
specifically supporting mucosal immunity by controlling the trafficking of responding 
cells. Indeed, the generation of key components of the mucosal immune system: IgA+ 
plasma cells, CD4+ Tregs and Th17 cells are all regulated by RA derived signals. In 
addition to controlling the tissue tropism of these cells, RA also influences the 
differentiation of cells towards lineages important for mucosal defense.  For instance, RA 
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signaling on B cells results in the selective promotion of intestinal IgA via enhancement 
of class switching to IgA 35, 36.  Notably, vitamin A metabolism plays a central role in the 
acquisition of oral tolerance, a process that requires peripheral generation of Foxp3+ 
Treg cells 37, 38.  Mice in which Foxp3+ Treg cells cannot be induced, failed to establish 
tolerance at mucosal surfaces and develop aberrant Th2 responses in both the lung and 
GI tract 37. The extrathymic differentiation of Foxp3+ Tregs in the GI tract is tightly 
controlled at steady state by the capacity of a specialized population of gut tropic DCs 
expressing CD103 that have a potent capacity to activate latent TGF-β and produce RA 
39, 40, 41, 42.  The effect of RA is not limited to regulatory responses as RA, in a context 
dependent manner, can promote effector T cell responses.  Indeed, vitamin A deficient 
mice have greatly diminished Th17 composition in their small intestines at steady state 
43, 44 and lower, physiologic, concentrations of RA can promote the differentiation and 
trafficking of Th17 cells to the small intestine 43, 44, 45.  As well, antigen presenting cells 
from vitamin A deficient mice are impaired in their ability to secrete IL-6, indicating that 
RA is important for the functional capacity of DC’s to promote TH17 differentiation 46.  
Thus, RA can promote both Treg and Th17 lineages in a context specific manner 21. 
Recent evidence suggests that retinoic acid may have a more general role in promoting 
both mucosal and peripheral immunity 46, 47. Indeed, impaired RARa signaling revealed a 
cell intrinsic role for RA sensing by naïve CD4+ T cells in order to achieve a proper 
threshold of TCR signaling and to become fully activated in the context of infection and 
skin allograft 46, 47. Both of these studies demonstrate that RA synthesis increases during 
systemic inflammation, likely in order to support various aspects of immune responses 
including T cell activation.  All together, recent work on the multifaceted role of retinoic 
acid begins to offer a mechanistic explanation for the profound immune deficiencies 
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associated with increased susceptibility to infections and poor vaccine responses 
observed in vitamin A deficiency.   
Notably, several recent studies have begun to apply these findings to clinical settings.  
Recent work demonstrated that the addition of RA at the time of peripheral vaccination 
has a profound capacity to increase the accumulation of memory cells in the gut mucosa 
48. Given the key role of RA in supporting effector responses, the peripheral 
administration of vaccines with RA provides an opportunity to not only target vaccines to 
mucosal surfaces, but to utilize RA as a vaccine adjuvant.  The role of RA in supporting 
effector responses during inflammatory settings has also been found to have deleterious 
effects.  In the context of Celiac disease, RA in combination with IL-15 can drive 
dendritic cell activation and production of IL12/23 p40 46. Such activation results in 
impaired Treg priming and augmented effector responses to the dietary gluten antigen, 
gliadin 46. Given the expanded knowledge of RA in regulating immunity, it will be 
important to further understand the contextual roles of RA, particularly in clinical settings.  
Vitamin A: the innate immune knowledge gap  
The role of vitamin A in supporting immunity has been an active area of research for 
nearly 85 years, and as early as 1928 the ability of vitamin A to augment immunity to 
infections was appreciated and it was labeled the “anti-infective vitamin”49.   Since that 
time, vitamin A deficiency has been shown to broadly impair many aspects of innate and 
adaptive immunity21, 50. Vitamin A deficiency results in decreased innate immunity via 
diminished neutrophil and macrophage mediated bacterial killing as well as decreased 
NK cell homeostasis and lytic acitivty51, 52, 53.   
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Despite the many years of research on vitamin A deficiency, knowledge pertaining to the 
impairments in innate immunity remains incomplete.  In particular, there are still many 
outstanding questions that have been raised by the renaissance that mucosal 
immunology has experienced in the last decade.  With a newfound appreciation that 
tissue-resident innate immune compartment is a key component of barrier defense and 
the discovery of a new cell type, the innate lymphoid cell (ILC)7, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63.  
As well, knowledge that these cell types interact directly with epithelial cells in the GI 
tract via the cytokines IL-22 and IL-13 64, 65, 66, leads to key outstanding questions that 
have not been examined:  
1) Are local, tissue-resident innate immune responses regulated by dietary 
vitamin A?   
2) Are the intestinal barrier defects and susceptibility to diarrheal disease 
observed in vitamin A deficiency a result of impaired immune responses? 
To address this question we will make use of a mouse model of dietary vitamin A 
deficiency.  As well, we will employ two infectious model systems to test the functional 
consequences of immune alterations: Citrobacter rodentium and Trichuris muris.   
 
Citrobater rodentium:  A  mouse model of human attaching/effacing (A/E) 
infectious diarrheal pathogens 
	  
After several outbreaks of diarrhea associated with high morbidity in mouse facilities 
across USA in the 1960’s it was determined that the causative agent was a mouse 
adapted bacterial pathogen now called Citrobacter rodentium 67.  Oral infection of mice 
with C. rodentium results in attaching/effacing (A/E) lesions in the colon that closely 
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resemble infection of humans with enteropathogenic Escherichia coli (EPEC) and 
enterohaemorrhagic Escherichia coli (EHEC).  This murine pathogen not only represents 
a model with which to probe host-pathogen interaction, but also is of high relevance to 
those with vitamin A deficiency.  In a study of vitamin A deficient children, a high 
incidence of enteroaggregative E. coli outgrowth was observed 68.  As well, in a recent 
study of malnourished children the presence of EPEC was associated with increased 
risk of death 69.  Work over the last decade has elucidated that the cytokine IL-22 is 
critical for clearance of C. rodentium and that there are relevant sources of IL-22 from 
both innate and adaptive immune cells64, 70, 71.  Results from these studies will be 
presented in chapter 4. 
Trichuris muris: A mouse helminth model of human whipworm infection 
Over 1 billion people worldwide and over 100 million preschool-age children are infected 
with the soil transmitted helminth Trichuris trichiura, also known as whipworm infection72.  
Endemic regions of malnutrition and vitamin A deficiency have a high degree of 
geographical overlap with areas of whipworm infection73 and whipworm infection is 
thought to be both a cause and consequence of malnutrition73.  Trichuris muris, a mouse 
whipworm, is used to model human whipworm infection in mice74.  Upon oral infection 
with T. muris eggs, the larvae hatch and infect the cecum of the mouse.   The type 2 
cytokines IL-13 and IL-4 are produced in large quantities after infection and are 
redundantly required for parasite clearance75, 76. We use this model to simulate 
environmental exposure to parasitic infections in vitamin A deficient children. Results 
from these studies will be presented in chapter 4. 
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CHAPTER 2:  INTESTINAL EOSINOPHILS CONTRIBUTE TO 
MUCOSAL IMMUNITY AND ARE REGULATED BY DIETARY VITAMIN 
A 
 
Abstract: 
Eosinophils comprise a sizeable portion of resident immune cells within the healthy GI 
tract of both mice (>15%)6 and humans (10-20eos/hpf)77.  Despite their prominence, the 
role of eosinophils in the regulation of GI immune responses remains unclear. Thus we 
investigated the role of eosinophils in promoting mucosal immune responses and GI 
specific factors important for their homeostasis and activation. Using an orally 
administered vaccine we found that eosinophils regulate antigen specific CD4+ T cell 
responses in the small intestine.  Administration of vaccine to mice selectively lacking 
eosinophils (ΔdblGATA), resulted in a decreased accumulation of antigen specific 
effector CD4+ T cells in the small intestine.  Conversely, in the absence of eosinophils 
we observed increased Treg conversion in response to orally administered antigen.  This 
suggests that the balance of effector and regulatory T lymphocytes in the intestinal 
mucosa is dynamically regulated by eosinophils.  To further dissect the mechanistic 
underpinnings of such control we assesses the gene expression profile of eosinophils 
purified from the intestine.  Consistent with their role in promoting intestinal CD4+ T cell 
effector responses, gastrointestinal eosinophils expressed increased levels of 
chemokines (MIP1-β, MIP1-α) and cytokines (IL-1α, IL-1β, and IL-6) that have been 
shown to be important for mounting effective immune responses in the gut.   We then 
investigated the upstream regulators of intestinal eosinophils and uncovered that Vitamin 
A and its nutrient metabolite RA critically control eosinophil homeostasis. All together, 
our data suggest that GI eosinophils have a crucial role in orchestrating vaccine induced 
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mucosal T cell responses and that a common dietary deficiency, Vitamin A deficiency, 
may impair the beneficial role of eosinophils in promoting intestinal immunity. 
 
Key Findings: 
• Intestinal eosinophils are dependent on retinoic acid for their homeostasis 
• In the absence of eosinophils: 
o Vaccine induced immune responses in the GI tract are impaired 
o Regulatory CD4+T cell priming is augmented  
o Small intestinal dendritic cells produce more IL-10 and less IL-6 
Introduction: Eosinophils in the healthy gut 
Eosinophils are classically considered end-stage effector cells that mediate their function 
through proteolytic and cytotoxic products78. Indeed, they are recruited to sites of Th2 
inflammation, typically associated with allergic responses and helminth infection, where 
they cause airway tissue damage in asthma or kill parasites during infection79, 80. In 
addition to their role in Th2 inflammation, eosinophils populate the healthy intestine of 
mouse and man77, 81,6. Their presence during steady state suggests a broader role for 
these cells in immunoregulation. Indeed, eosinophils have only minor contributions to 
anti-parasitic Th2 responses in the intestine82, 83, 84. A recent report demonstrated that 
human eosinophils have the capacity to make a diverse array of inflammatory cytokines 
associated with both Th1 and regulatory responses85. Despite these data, the role of 
eosinophils in steady state and during Th1 and Th17 inflammation in the GI tract is 
poorly understood. 
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Eosinophils and inflammatory diseases  
Dysregulation of the immune system in the GI tract leads to the IBD (Ulcerative Colitis 
and Crohn’s)86. Although the etiology remains unclear, evidence supports that IBD 
results from a disturbed interaction of the immune system with commensal microbiota87. 
A common feature of IBD is increased numbers of eosinophils in diseased tissue88, 89. 
Eosinophils contribute to tissue pathology as eosinophil cytotoxic proteins are found in 
biopsy specimens of IBD patients90, 91. As well genetic deletion of the eosinophil 
peroxidase decreased pathology in a mouse model of colitis92. Despite strong evidence 
that eosinophils contribute directly to tissue damage during intestinal inflammation, if and 
how eosinophils are contributing to the etiology or pathology of inflammatory bowel 
diseases by either direct production of cytotoxic molecules or indirectly through 
regulation of tissue immune responses requires elucidation. 
 
Eosinophils develop in the bone marrow where they depend on common-β chain 
signaling of IL-5, GMCSF and IL-378.  Mature eosinophils express CCR3, which binds to 
Eotaxin family members and mediates recruitment of eosinophils to tissues in 
cooperation with IL-5.  Although eosinophils principally migrate to the GI tract, their 
presence is independent of commensal stimuli. Eosinophil recruitment to the gut occurs 
before birth, preceding bacterial colonization and eosinophils are present in normal 
amounts in the GI tract of germ free mice6. Recent evidence suggests that eosinophils 
contribute to metabolic homeostasis and raises the possibility that a dietary component 
may be regulating eosinophil homeostasis in the GI tract93.  Yet, surprisingly little is 
known about dietary and metabolic factors that may regulate the recruitment and 
survival of eosinophils in the GI tract.  
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We and others have found that Vitamin A, which acts through its metabolite retinoic acid 
(RA), is a critical mediator of intestinal immune homeostasis94, 95. The possibility that RA 
is regulating eosinophil homeostasis is supported by recent data showing that human 
eosinophils express RA receptors (RAR) and that RA promotes eosinophil survival and 
expression of chemotaxis molecules in vitro96, 97. However, the role of RA in supporting 
eosinophil homeostasis in vivo and the extent to which eosinophils contribute to immune 
dysfunction observed in VAD has not been examined.   Thus, we hypothesized that 
eosinophils present in the GI tact would be dependent on dietary derived signals 
for their homeostasis and that they would contribute to immune responses in the 
GI tract.  
Results:  
Eosinophil homeostasis  and activation in the GI tract is dependent on 
dietary vitamin A 
	  
To examine the role of intestinal eosinophils in intestinal homeostasis we first 
established a gating strategy for identification and sorting of these cells (Figure 1A).  As 
previously reported 5, the small intestinal eosinophil was SSChi, CD11b+, CD11c+, Siglec 
F+, MHCII— (Fig 1A, data not shown).  Indeed, cells sorted CD45+, live, SSChi, MHCII- 
cells from the small intestine had the histologic appearance of murine eosinophils 
(circular nucleus and plentiful eosinophillic granules) 5.  
We next sought to identify the factors required for eosinophil homeostasis in the GI tract.   
The properties of the GI tract that make it the principle source of eosinophils at steady 
state remain unknown.  Previous reports indicate that in germ free mice intestinal 
eosinophil homeostasis is not affected 6.  Recent data indicates that RA, the principle 
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vitamin A metabolite, can directly promote human eosinophil survival in vitro96.   
Moreover, this nutrient metabolite has been implicated in regulating the recruitment and 
function of numerous other immune and non-immune cells in the intestinal mucosa. 
Thus, we examined the role of vitamin A in mediating eosinophil homeostasis. Mice were 
made Vitamin A insufficient (VAI) through a protocol of dietary restriction95. We then 
examined by the abundance of eosinophils in the small intestine lamina propria (SiLP) 
(Figure 1B).  We found that vitamin A deficiency dramatically impairs both the 
percentage of eosinophils and the total numbers present in the siLP (Figure 1B).   
To examine the role of retinoic acid signaling in eosinophil homeostasis we made use of 
a pan- retinoic acid receptor (RAR) signaling inhibitor BMS49398.   Thus, we acutely 
inhibited RA signaling by treating mice with the pan-retinoic acid receptor inhibitor 
BMS493 (RAi) for 8 days (Figure 1C).  Both the percentage and total numbers of 
eosinophils in the SiLP was greatly reduced.  We also wanted to concurrently test, 
whether intestinal flora played a role in the reduction of eosinophils we observed in the 
absence of retinoic acid signaling.  Thus, we also treated germ free (GF) mice with the 
RAi (Figure 1C).  In accordance with previous literature, eosinophils were not only  
present in the SiLP of GF mice, but were significantly increased in total numbers as 
compared to conventionally raised specific pathogen free (SPF) control mice (Figure 
1C).  After administration of the RAi, the total number of eosinophils was reduced to 
levels seen in RAi treated SPF mice (Figure 1C).  Thus, the decreased numbers of 
eosinophils in the GI tract seen with the RAi treatment is likely independent of the 
presence of commensal flora.   
Although eosinophils become activated in tissues, it is not understood how their 
functional properties are altered99.  To address this, we compared the global 
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transcriptional profile of SiLP eosinophils to mature eosinophils in the bone marrow 
(Figure 2A). We analyzed the microarray by performing a principle coordinate analysis 
(Figure 2B).  SiLP eosinophils were indeed transcriptionally distinct from mature bone 
marrow eosinophils.  We confirmed previous reports that GI eosinophils have increased 
levels of activation induced molecules (Fig 2C). Surprisingly, despite increased 
activation, the canonical eosinophil effector proteins (eosinophil peroxidase and major 
basic protein) were the most down regulated genes in GI eosinophils (Fig 2C). The 
genes most significantly upregulated were IL-1 cytokines and chemokine molecules (Fig 
2C). These data suggest that intestinal eosinophils have distinct functional properties 
and that adopt a unique phenotype associated with the intestinal mucosa.   
We next assessed what factors regulated the effector potential of eosinophils in the GI 
tract.  As IL-1β was the most significantly upregulated gene identified from our 
microarray analysis, we measured IL-1β protein in germ free and vitamin A deficient 
settings (Figure 3).  Intestinal eosinophils from germ free mice had comparable levels of 
IL-1β expression as control SPF mice (Figure 3A).  In contrast, levels of IL-1β are almost 
completely lost in a vitamin A deficient setting (Figure 3B).  Importantly, upon a short 
course of reconstitution with RA, partially restored the production of IL-1β from 
eosinophils (Figure 3B). Thus, in mice deficient in Vitamin A, both intestinal eosinophil 
homeostasis and activation is impaired.   
Eosinophils regulate CD4+ T cell responses in the GI tract 
The role of GI eosinophils in promoting vaccine induced immunity and Th1 immune 
responses in the GI tract is unknown. The current paradigm suggests that in the 
absence of Th2 associated eosinophils Th1 responses would be augmented. To test 
this, we made use of an eosinophil deficient mouse strain, ΔdblGATA, on a full C57Bl/6 
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background100, 101.  We vaccinated ΔdblGATA mice with OVA and the mucosal Th1 
adjuvant, LT(R129G/L211A) twice over the course of 14 days (Figure 4A)95, 102. We 
observed, however, that ΔdblGATA mice have reduced antigen specific Th1 
responses(Figure 4B). Thus, these findings broaden our understanding of tissue 
eosinophils to include the promotion of vaccine induced CD4+ T cell responses in the GI 
tract. 
After making the observation and eosinophil deficient mice have impaired vaccine-
induced T cell responses, we hypothesized that intestinal eosinophils promote effector 
responses in the GI tract. Hence, we sought to examine if, in the absence of eosinophils, 
regulatory responses were favored. To probe this, we used a well established method to 
generate inducible Tregs In vivo in an antigen specific manner via oral feeding of the 
model antigen, OVA41(Figure 5A). We found that eosinophil deficient mice have 
increased conversion of Treg cells in the small intestine after 7 days of feeding (Figure 
5B). This indicates that in mice lacking eosinophils there is a altered balance between 
effector and regulatory responses that favors regulatory responses.  
In an attempt find a mechanism for this altered balance we probed dendritic cell function 
in ∆dblGATA mice. Previous reports demonstrate eosinophil mediated activation of 
dendritic cells 103, 104. We found that in the absence of eosinophils, SiLP DC’s produce 
less proinflammatory cytokine (IL-6) and more regulatory cytokine (IL-10) (Figure 5C). 
Thus, eosinophils may modulate mucosal T cell responses by either acting directly on T 
cells or indirectly by influencing intestinal DC cytokine production.   
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Discussion:  
Eosinophils are tissue-resident cells present in the intestine of healthy humans and mice 
6, 77, 105.   Although their presence in the GI tract is appreciated, the environmental signals 
required for their recruitment to and activation at this site are still unclear5, 6, 106.  As well, 
there is still a lack of understanding regarding their function.  We have found that dietary 
vitamin A is a dominant signal regulating eosinophil homeostasis in the GI tract (Figure 
1).   Via transcriptional analysis of intestinal eosinophils as compared to mature bone 
marrow eosinophils, we found that intestinal eosinophils upregulate genes encoding the 
inflammatory cytokines IL-1β and IL-1α (Figure 2) and that expression of IL-1β is 
dependent on dietary vitamin A (Figure 3).   As IL-1β is known to promote vaccine 
responses, we next probed the role of intestinal eosinophils in promoting vaccine 
induced immunity in the intestine107.  We found that ∆dblGATA mice lacking eosinophils 
had impaired antigen specific vaccine responses in the intestine (Figure 4).   All 
together, these data suggest that eosinophils in the intestine are recruited and activated 
by dietary vitamin A.  Further, their activation in the GI track results in increased levels of 
pro-inflammatory cytokines that may lead to their support of effector T cell response in 
the intestine.   
We next asked if intestinal eosinophils, while promoting effector responses, would 
conversely inhibit regulatory responses. Indeed, we found that the absence of 
eosinophils resulted in increased rates of CD4+Treg induction towards orally 
administered antigen (Figure 5).   To explore the mechanism by which eosinophils were 
regulating CD4+ T cell responses in the GI tract we examined if the dendritic cell 
compartment of eosinophil deficient mice was altered.  Indeed, we found that intestinal 
DCs from eosinophils deficient mice had a higher proportion of cells producing the 
	  
	  
17	  
regulatory cytokine IL10+ shown to promote CD4+ T reg expansion in the intestine and 
limit effector T cell responses108.   This is in line with previous findings that eosinophils 
can directly promote DC activation via their secreted products 103, 104.  Thus, in the 
healthy gut eosinophils may be important mediators in supporting the effector tone of the 
gut and preventing excessive regulatory responses via activation of DCs.   
The implication of these finding are two fold. First, given the importance vitamin A in 
supporting eosinophil homeostasis and activation in the GI tract, vitamin A deficiency 
likely results in a loss of the beneficial role of eosinophils.  Vitamin A deficiency results in 
dramatically impaired responses to oral vaccination95, and it is possible that some 
degree of this poor responsiveness is directly due to impaired eosinophil homeostasis 
and function.  Secondly, these results imply that in states of hypereosinophillia such as 
eosinophillic esophagitis (EOE) and eosinophillic gastrointestinal disorder (EGID) that an 
abundance of eosinophils may inhibit regulatory responses to dietary antigens.  This 
would create a feed forward loop propagating eosinophilia and limiting intestinal 
regulatory responses.   All together, these findings uncover a novel role for dietary 
factors in the control of gastrointestinal eosinophils and underscores the importance of 
eosinophils in the regulation of mucosal CD4+ T cell responses. 
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Figure 1 
	  
Figure 1:  Intestinal Eosinophils are dependent on retinoic acid signaling:  A) Flow 
cytometric analysis of cells isolated from small intestinal lamina propria (SiLP), lung and skin 
of naïve C57Bl/6 mice.  Cells were FACS purified as CD45+, Dapi-, Siglec F+ and MHCII- and 
stained with H&E.  B) Cells isolated from the SiLP of control (Ctrl) or vitamin A insufficient 
(VAI) C57Bl/6 mice gated on CD45+, DAPI-, Siglec F+, MHCII- and quantified total numbers 
of eosinophils in the SiLP.  C) CD45+, DAPI-, Siglec F+, MHCII- cells from the SiLP of specific 
pathogen free (SPF) or germ free (GF) mice treated with vehicle control (Veh) or retinoic acid 
receptor inhibitor (RAi) for 8 days and quantified total numbers of eosinophils in the SiLP.   
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Figure 2 
	  
	  
Figure 2: Gene expression profile of small intestinal eosinophil reveals unique 
activation profile:  A) schematic of experimental strategy to compare the mRNA 
expression profiles of mature bone marrow eosinophis (SSChi, Siglec F+, CCR3+, 
CD11b+) to small intestinal eosinophils (SSChi, Siglec F+, CD11b+, MHCII-) using whole 
mouse genome microarray. B)Principle coordinate analysis (PCA) using the transciptional 
profile of SiLp eosinophils and mature bone marrow C) Top immune genes 
upregulated,downregulated, and unchanged genes. 
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Figure 3 
	  
Figure 3:  eosinophil activation in the GI tract is commensal independent and 
Vitamin A dependent A) Cells isolated from the small intestinal lamina propria (SiLP) 
of specific pathogen free (SPF) or germ free (GF) mice and gated on gated on CD45+, 
Live, SSChi, CD11b+, Siglec F+ eosinophils were examined for the presence of IL-1β 
directly ex vivo by intracellular cytokine staining. B) CD45+, Live, SSChi, CD11b+, 
Siglec F+ cells from the SiLP of control (Ctrl), vitamin A insufficient (VAI) or VAI treated 
with all-trans retinoic acid every three days for 10 days (VAI + RA) examined for the 
presence of IL-1β directly ex vivo by intracellular cytokine staining. 
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Figure 4 
	  
Figure 4: Vaccine induced CD4+ T cell responses are impaired in the absence of 
eosinophils A) schematic of oral vaccination of ΔdblGATA mice on D0 and D7 with	   a 
mixture of OVA and the mutant E. coli labile toxin, LT(R192G/L211A) with responses 
tested on D14. B)T cells were purified from the small intestinal lamina propria (SiLP) of 
vaccinated WT or ΔdblGATA mice on day 14 and were cultured with splenic DCs + OVA. 
Intracellular cytokine staining of IFN-γ in  live,CD4+ TCRβ+cells and quantification of total 
numbers of all IFN-γ and IL17A+ antigen specific T cells.  
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Figure  5 
	  
Figure 5: In vivo induction of Tregs is augmented in eosinophil deficient mice A) 
1e6 CD45.1+ OTII cells were transferred to either WT or ∆dblGATA CD45.2 mice. 24 
hours after transfer mice were administered OVA in their drinking water for 6 days B) at 
day 7 of OVA feeding cells were isolated from the small intestine and stained for the 
transcription factor Foxp3 (gate on live, CD4+, TCRβ+) C)SiLp cells stimulated with 
CpG (ODN 1826) for 4h. Intracellular cytokine staining for IL-6 and IL-10. LpDC gated 
on live, CD11chi,MHCIIhi 
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Figure 6 
	  
Figure	  6:	  Schematic	  of	  homeostasis	  and	  function	  of	  intestinal	  eosinophils.	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CHAPTER 3:  INTESTINAL DENDRITIC CELL HOMEOSTASIS IS 
REGULATED BY RETINOIC ACID 
 
Abstract:  
Dendritic cells (DCs) are present in most tissues with distinct and specialized roles at 
each site.  It remains unclear how local tissue specific factors regulate the adaptation of 
DCs within their tissue of residence.  In the intestine there are three main subsets of 
DCs that can be discriminated based on surface expression of CD103 and CD11b.  
Herein, we find that dietary vitamin A is a dominant signal in the control of intestinal 
dendritic cell homeostasis.  Vitamin A insufficient (VAI) mice have a specific reduction in 
CD103+CD11b+ intestinal DCs.  Further, via restoration of retinoic acid (RA) to VAI mice 
or blockade of RA signaling in WT mice, we demonstrate that CD103+CD11b+ DCs are 
uniquely dependent on RA signaling for their homeostasis in the GI tract.  Further, we 
evaluated retinoid levels in mice and humans after radiation-induced mucosal injury and 
found this conditioning led to an acute VAI state. Consequently, radiation led to a 
selective loss of intestinal RA-dependent DC subsets.  To investigate the role of DC 
intrinsic RARα signaling, we generated a novel line of mice in which RARα was 
conditionally deleted in DCs (RARαDCKO). The homeostasis of CD103+ DCs in the 
RARαDCKO was intact, while their unique ability to synthesize RA via RALH enzymes 
was lost entirety.  These data indicate an indirect role for RA in the control of DC 
homeostasis, but a direct role of RARα dependent signaling on DCs for the synthesis of 
RA.  All together, these results identify dietary vitamin A and retinoic acid signaling as a 
key mediator of intestinal DC homeostasis and function.  
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Key findings: 
• CD103+CD11b+ intestinal DC’s are dependent on retinoic acid for their 
homeostasis 
• Total body irradiation induces a vitamin A insufficient state and results in a loss of 
CD103+CD11b+ DC’s 
• Generation of a DC specific RARα deleted mouse (RARαDCKO) indicated the 
following: 
o Intestinal DC homeostasis is not mediated via RARα signaling in DC’s 
and the effect of RA on DCs is likely indirect. 
o RALDH expression by CD103+ DC’s is directly and absolutely dependent 
on DC intrinsic RA signaling via RARα 
Introduction:  Intestinal Dendritic cells 
Dendritic cells (DC) are myeloid derived innate immune cells that are key mediators in 
the dialogue between innate and adaptive immune system by serving as antigen 
presenting cells to naïve T cells109.  They are present in secondary lymphoid tissue, 
internal organs, and at barrier tissue sites110.  DCs residing at barrier tissue sites such as 
the gut function as sentinels that induce adaptive T cell responses via the sensing of 
environmental cues and presentation of foreign antigen.  The composition of the 
dendritic cell network at barrier sites is highly diverse and unique to each barrier site, 
which allows for a flexibility in the face of the multitude of possible pathogen present at 
each site110. 
In the GI tract DC’s possess unique properties tailored to their function in this tissue.  At 
steady state, they sample luminal antigen for the priming of homeostatic T and B cell 
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responses in the draining lymphoid tissue while during inflammation, they prime effector 
responses to defend against invading pathogens29, 111.  Intestinal DC’s express high 
levels of enzymes necessary for production of retinoic acid (RA)41, 42.  This in 
combination with increased TGF-β activating potential endows them with augmented 
ability to prime Treg responses in the gut39.  As well data now supports an important gut 
resident role for dendritic cells in the production of cytokines IL-23 and IL-25 that tune 
local innate immune response112, 113, 114.  
The intestinal DC compartment is composed of 3 subsets: 1- CD103+,CD11b— 2- 
CD103+,CD11b+ 3- CD103—,CD11b+ (Figure 7A).  The first two subsets, CD103+, 
CD11b- and CD103+CD11b+ are derived from a circulating common DC precursor 
(CDP) and secrete high levels of IL23 and IL6 8, 115, while the CD11b+CD103- subset 
derives from a macrophage-DC precursor (MDC) and secretes IL10.  It is thought that 
the respective precursors to these three subtypes of DCs migrate to the GI tract where 
their terminal differentiation takes place.  Thus, the tissue microenvironment of the 
intestine determines the differentiation of DC precursors that arrive in the GI tract.   
 
Reports have demonstrated that the CD103+CD11b+ as well as the CD103+CD11b- are 
bone fide migratory subsets that present luminal antigen in the mesenteric lymph node 8, 
115.  Importantly, both CD103+ subsets express high levels of RALDH enzyme in order to 
synthesize the vitamin A metabolite retinoic acid (RA) that promotes trafficking to the 
small intestine and priming of Treg and Th17 responses29. The CD11b+,CD103- 
macrophage-like DC population appear to be non-migratory and serve the tissue 
resident function of secreting high levels of IL-10 to promote Treg stability in the small 
intestine 108. 
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Although the unique phenotype and functionality of intestinal dendritic cells is now well 
appreciated, the mechanism by which intestinal dendritic cells adopt a gut specific 
phenotype still remains elusive.  Commensal bacterial do not appear to play a definitive 
role in intestinal DC homeostasis, though this has not been formally assessed116, 117.  It 
remains unknown to what extent intestinal DC homeostasis is reliant on dietary signals 
and in particular dietary vitamin A.  Thus, we hypothesized that Vitamin A controls 
both the homeostasis and function of the small intestinal dendritic cell 
compartment.   
Results 
CD103+ intestinal dendritic cell homeostasis is controlled by vitamin A 
To test the influence of vitamin A on intestinal DC homeostasis, we made mice vitamin A 
insufficient (VAI) via dietary restriction of vitamin A.  We observed a striking decrease in 
CD103+CD11b+ SiLP DC subset, while the CD103+CD11b- subset was mildly 
increased in frequency and the CD103-CD11b+ subset was unaltered (Figure 7B and 
C).   We next supplemented VAI mice with RA over the course of 8 days to evaluate if 
SiLP DC homeostasis could be restored as well as to test if RA was a downstream 
metabolite of vitamin A conferring its function. Indeed, supplementation with RA restored 
all subsets to the levels seen in control mice (Figure 7B and C).   
 
To further examine the role of RA signaling in dendritic cell homeostasis we made use of 
a pan- retinoic acid receptor (RAR) signaling inhibitor BMS49398.   We acutely inhibited 
RA signaling by treating mice with BMS493 (RAi) for 8 days (Figure 8A and B).  As in 
vitamin A deficiency, we observed a dramatic decrease in CD103+CD11b+ DC, while 
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CD103+CD11b- were significantly increased (Figure 8A and B).    Thus, the 
CD103+CD11b+ subset appears to be uniquely reliant on retinoic acid for their 
homeostasis, while the CD103+CD11b- subset was augmented by deprivation of retinoic 
acid signaling. 
Total body irradiation leads to induced vitamin A deficiency and altered DC 
homeostasis 
	  
Given the importance of vitamin A in controlling intestinal DC homeostasis, we sought to 
identify clinically relevant settings in which vitamin A deficiency may occur.   Higher 
mammals depend entirely on dietary vitamin A as they lack the capacity for vitamin A 
synthesis and must absorb vitamin A in the small intestine 118. Because total body 
irradiation (TBI), a component of standard preparative regimens used to facilitate 
autologous and allogeneic stem cell transplantations and experimental 
immunotherapies, causes significant injury to both the small and large intestines, we 
evaluated whether such conditioning could induce a VAD state in both humans and mice 
119 120, 121 122, 123.  We found that patients with metastatic melanoma receiving TBI as part 
of an autologous adoptive T cell transfer (ACT) immunotherapy developed a time-
dependent loss in circulating levels of retinyl ester (RE), the primary form of vitamin A as 
it enters circulation after absorption from the gut (Figure 9A)118, 121. The degree of RE 
loss correlated with the magnitude of weight loss experienced by this cohort of patients, 
implying a relationship between the ability to absorb dietary-derived nutrients and 
vitamin A sufficiency (Figure 9B). These findings were confirmed in mice receiving TBI in 
which serum levels of both RE and RA themselves were significantly depleted relative to 
nonirradiated controls to a level comparable to that of VAI mice (Figure 9C). We next 
examined the effect of TBI on SiLP DCs in mice. Consistent with previous results using 
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VAI or RAi treated mice, we observed a loss in the total number of CD103+CD11b+ 
SiLP DCs , while the total numbers of CD103+ CD1b- and CD103-CD11b+ DCs were 
not effected (Figure 9  D and E).  Thus in a setting of TBI, a similar alteration in DC 
homeostasis occurs as in a vitamin A deficient setting.  
RA mediated control of intestinal DCs involves both RARα dependent and 
RARα independent pathways in DCs 
 
The previous set of experiments did not probe the cell types with which RA was 
interacting with directly.  To investigate this we newly generated a mouse with the RARα 
gene (RARA) flanked by loxp sites (RARa fl/fl mouse) that we crossed to a CD11C-cre 
mouse 124 to generate a lineage restricted deletion of RARa specifically in dendritic cells 
(RARαdcKO mouse).  We found that the homeostasis of intestinal DCs was not affected 
by deletion on RARα (Figure 10A and data now shown).  This indicates that the effect of 
retinoic acid on DC homeostasis is not mediated via RARα signaling in intestinal DC’s.  
We next assessed one of the keystone functions of the CD103+ intestinal DCs, the 
ability to synthesize RA via RALDH enzymes. To test this we made use of an assay that 
allows for detection of RALDH expressing cells via exposure to a substrate that 
fluoresces In the presence of RALDH enzymes (ALDEFLUOR™, Stemcell 
Technologies)125. The absence of RARα signaling on DCs entirely impairs the ability of 
CD103+ SiLP DCs to express RALDH enzymes (Figure 10B).  Thus, although the 
homeostasis of SiLP DC’s is not dependent on RARα, their production of RA appears to 
be absolutely dependent on DC intrinsic RARα expression.   
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Discussion:  
Dendritic cells in the intestine are unique and highly specialized to support immune 
responses in the GI tract29.  Via the synthesis of retinoic acid, CD103+ intestinal DCs 
promote intestinal homing of adaptive immune cells as well as support priming of both T 
regulatory and TH17 responses29, 95.  Deriving from the circulating common DC 
precursor, the tissue microenvironment is thought to determine DC differentiation and 
specialization in the GI tract.   We investigated the role of dietary vitamin A and retinoic 
acid signaling in the control of DC homeostasis in the GI tract.  Our findings indicate that 
CD103+CD11b+ DCs are reliant on retinoic acid for their presence in the intestine, while 
CD103+CD11b- and CD103-CD11b+ differentiate independent of retinoic acid (Figure 7 
and Figure 8).  In addition to dietary vitamin A deficiency, we identified acute total body 
irradiation (TBI) as a potential source of vitamin A deficiency, likely occurring secondary 
to the severe mucosal injury that occurs as a result of TBI (figure 9) 119 120, 121 122, 123.   
The vitamin A deficient state induced by TBI is correlated with a similar loss of 
CD103+CD11b+ DCs.   
 
There are key questions left unanswered by these data in terms of the mechanism by 
which retinoic acid supports intestinal DC homeostasis.  Chiefly, through which receptor 
is RA mediating its action and on what cell type/types is it signaling? Using a lineage 
specific deletion of RARα in dendritic cells we determined that the presence of 
CD103+CD11b+ DCs in the GI tract is not directly dependent on RARα (Figure 10).  It is 
possible that RA is signaling via RARγ in dendritic cells as this receptor is expressed in 
dendritic cells (Data not shown) or that RA is acting indirectly. Recent findings indicate 
that CD103+CD11b+ DCs are selectively dependent on notch signals via notch2 ligands 
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for their development in the GI tract 112, 126, 127, 128. As well, the population of notch-
dependent DCs in the spleen that is developmentally related to the CD103+CD11b+ 
intestinal DC was recently shown to be retinoic acid dependent 127.  Given that retinoic 
acid has previously been shown to augment notch signaling pathways 126, RA be acting 
indirectly to influence the notch pathway either by upregulating notch or notch ligands.  
 
While it is likely that retinoic acid is acting in the intestinal tissue, it is also possible that 
retinoic acid signaling is also acting on the cDC precursor before it arrives in the gut.  
Indeed, a recent report identified a subset of cDC that expressed gut homing markers 
termed pre-mucosal DCs (pre-µDCs) that was reduced in vitamin A deficiency and 
during RAi treatment 129.  The stage at which RA is acting to influence DC development 
remains unclear and warrants further investigation.  As well, given that DC homeostasis 
was not effected in RARαdcKO it will be important to determine if an indirect interaction is 
involved in mediating the effect of RA on pre-µDCs. 
 
Although CD103+ DCs were present in RARαdcKO mice, the expression of RALDH 
enzymes was entirely lost (Figure 10).  This indicates that RARα signaling in DCs is 
critical for CD103+ DCs to become functionally specialized in the GI tract.  Given the 
limited scope of phenotypic evaluation beyond RALDH expression, it will be critical to 
evaluate the cytokine production and T cell priming capacity of the CD103+ DCs from 
RARαdcKO mice both in vitro and in vivo.  All together, we have identified retinoic acid a 
dominant signal controlling both the homeostasis and functional capacity of CD103+ 
DCs in the intestine.  The loss of this subset of DC’s likely contributes to the 
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immunosuppression and vaccine hypo-responsiveness and susceptibility to infection in 
vitamin A deficiency.   
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Figure 7:   
	  
Figure 7:  Dietary vitamin A regulates intestinal CD103+ DC homeostasis A) A 
schematic describing the properties of the three intestinal DC subsets.  B) Cells 
isolated from the small intestinal lamina propria (SiLP) of control (Ctrl), vitamin A 
insufficient (VAI) or VAI treated with all-trans retinoic acid every three days for 10 days 
(VAI + RA) gated on CD45+, Live, MHCIIhi, CD11chi cells and stained for CD103 and 
CD11b and C) quantification of percentage and total numbers of DC subsets.  
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Figure 8: 
	  
Figure 8:	  	  Acute blockade of retinoic acid signaling results in altered CD103+ DC 
homeostasis A) Cells isolated from the small intestinal lamina propria (SiLP) of mice 
treated with vehicle control (Veh) or retinoic acid receptor inhibitor (RAi) for 8 days 
gated on CD45+, Live, MHCIIhi, CD11chi cells and stained for CD103 and CD11b and 
B) quantification of percentage and total numbers of DC subsets.  
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Figure 9: 
	  
Figure 9: Total body irradiation (TBI) induces an acute vitamin A depleted state in 
humans and mice and a selective loss of CD103+CD11b+ DCs. Patients with 
metastatic cutaneous melanoma and mice maintained on a normal (Ctrl) diet bearing 
B16 melanoma tumors received blood draws before and after TBI. (A and B) 
Quantification of serum RE levels A) and correlation of serum RE levels with fractional 
changes in body weight B) in patients with metastatic melanoma before and after 
receiving TBI conditioning for autologous ACT immunotherapy; n = 3–8 patients/time 
point. C) Quantification of serum RE and RA levels in Ctrl diet tumor-bearing mice 10 d 
after receiving sham treatment or TBI and non-irradiated VAI diet mice.  D) Cells isolated 
from the small intestinal lamina propria (SiLP) of mice who received either sham 
treatment or 6 Gy of TBI 10 d prior gated on CD45+, Live, MHCIIhi, CD11chi cells and 
stained for CD103 and CD11b and E) quantification of percentage and total numbers of 
DC subsets.  
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Figure 10: 
	  
Figure 10: A) Cells isolated from the small intestinal lamina propria (SiLP) of CD11ccre 
negative (Ctrl) RARαfl/fl mice and CD11ccre positive RARαfl/fl littermates 
(RARαDCKO).  Cell were gated on CD45+, Live, MHCIIhi, CD11chi cells and stained for 
CD103 and CD11b and the percentage and total numbers of DC subsets were 
quantified.  B)  Live SiLP DC’s were incubated with ALDEFLUOR to detect RALDH 
activity. Ctrl cells were also incubated with an inhibitor of RALDH activity DEAB as a 
negative control.   
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Figure 11: 
	  
Figure 11: Model of Vitamin A influence on DC homeostasis in the GI tract 
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CHAPTER 4: ADAPTATION OF INNATE LYMPHOID CELLS TO 
NUTRIENT DEPRIVATION PROMOTES TYPE 2 BARRIER IMMUNITY 
 
Abstract 
 
Survival of the host relies on establishment of site-specific barrier defense tailored to 
constrain pressures imposed by commensal and parasitic exposures. The host is 
confronted with the additional challenge of maintaining immunity in fluctuating states of 
dietary availability, yet how the immune system adapts to nutritional states remains 
unclear. Here we show that the essential nutrient vitamin A regulates an inverse balance 
between innate lymphoid cell (ILC) subsets by promoting IL-22 producing ILC3 while 
directly suppressing IL-13 producing ILC2.  Consequently, Vitamin A deficiency results in 
impaired immunity against bacterial infection and a reciprocal increase in type 2 
responses to worm infection. These results reveal micronutrients as a novel instructive 
cue guiding ILC fate. Thus, in settings of malnutrition, a switch to type 2 immunity 
imposed by limited Vitamin A availability may represent a powerful adaptation of the 
immune system to promote host survival in the face of ongoing barrier challenges. 
Key findings: 
	  
• Dietary vitamin A controls in inverse fate and function of intestinal ILCs 
o ILC3 numbers and function are impaired resulting in decreased IL-22 secretion  
o ILC2 numbers and function are augmented resulting in augmented IL-13 
secretion 
• Vitamin A deficiency results in dramatic susceptibility to attaching/effacing diarrheal 
pathogen C. rodentium that can be rescued with administration of exogenous IL-22 
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• Vitamin A deficiency results in augmented protection against low-dose helminth infection 
with T. muris  
Introduction: Innate Lymphoid Cells are potent mediators of barrier defense 
Maintenance of barrier defense is an essential component of mammalian host 
health and survival. Intestinal immunity has evolved in the context of constitutive 
exposure to commensal microbiota and chronic worm infections as well as periodic 
encounters with acute pathogens. Notably, the gastrointestinal (GI) tract is home to an 
estimated 100 trillion commensals, and over 1.5 billion humans remain chronically 
infected by parasitic worms130, 131. Over the course of evolution, maintenance of barrier 
immunity had to adapt to unstable nutritional availability. Although some reports indicate 
dietary ligands are sensed by the immune system16, 17, 18, 19, how the immune system 
integrates dietary cues in order to tune immune responses according to the nutritional 
state of the host remains unclear.  
Innate lymphoid cells (ILC) are potent innate mediators of barrier maintenance, 
tissue repair, and host defense132, 133, 134. Several subsets of ILC with distinct phenotypes 
and functions have been described with two dominant tissue resident subsets 
associated with barrier defense and tissue repair135. Group 2 ILC (ILC2) produce IL-5, IL-
9 and IL-13, are dependent on GATA3 and RORα for their development and contribute 
to tissue homeostasis and immunity against worm infections7, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63. 
Innate lymphoid cells expressing RORgt are classified as group 3 (ILC3)136 and produce 
IL-22 that is important for containment of commensal bacteria and defense against acute 
intestinal bacterial pathogens64, 134. 
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Additionally, ILC have been proposed to contribute to metabolic homeostasis through 
the control of yet unidentified mediators137. Although they are lymphoid in origin, these 
cells lack antigen specific receptor expression and, in the GI tract, the homeostasis of 
ILC, as well as their capacity to produce cytokines, is largely independent of commensal 
bacteria138,114. Together, this raises the possibility that intestinal ILC composition could 
be controlled by dietary signals. As such, ILC may tailor their support of barrier function 
to the nutritional landscape of the host and may be ideally positioned to adapt their 
functional program to respond to the severe stresses imposed by malnutrition. 
One of the most common and severe nutrient deficiencies, affecting an estimated 
250 million preschool age children is vitamin A deficiency139.  Notably, this commonly 
occurs in settings of severe malnutrition and concurrent chronic worm infections 139. This 
essential dietary nutrient, via its metabolite retinoic acid (RA) that is highly enriched in 
the gastrointestinal tract, supports local B and T cell immunity20, 21.  Accordingly, vitamin 
A deficiency associated with malnutrition has long been linked to immunosuppression 
and increased incidence and duration of acute diarrheal disease in children68,140.  
Herein, we hypothesize that ILC mediated control of tissue immunity could be 
regulated by essential micronutrients and, in particular, Vitamin A.  Further, we 
examine the possibility that ILC may be primary sensors of dietary stress and 
sustains barrier function in the context of nutrient deficiencies.      
Results:   
Dietary vitamin A controls in inverse fate and function of intestinal ILCs 
 
As previously shown, at steady state, RORγt+ ILC3 were dominantly present in the gut 
while the majority of ILCs residing in the lung or skin belonged to the GATA3 expressing 
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ILC2 subset57, 63, 141 (Fig. 1A and B). This observation suggests that steady state 
distribution of ILC is likely controlled by local cues. One dominant factor present in the 
gastrointestinal tract is the vitamin A metabolite retinoic acid (RA)21.   
To explore the possibility that vitamin A may control ILC populations, we isolated cells 
from the small intestine lamina propria (SiLP) of mice placed on a Vitamin A deficient 
diet (vitamin A insufficient (VAI) mice). Strikingly, the frequency of ILC3 as well as their 
total abundance was greatly reduced in VAI wild-type (WT) mice (Fig. 1C and D). In 
sharp contrast to defects in ILC3, we observed a significant increase in the frequency 
and absolute numbers of GATA3+ ILC2 in VAI mice (Fig. 1C and D). Altered frequencies 
of ILC populations were also evident in VAI mice lacking T and B cells (VAI Rag1–/–), 
although the overall amount of ILC was increased (Fig. 1C and E). Furthermore, 
expression of IL-22 from intestinal ILC was severely impaired in VAI WT and Rag1–/– 
mice in comparison to control mice (Fig. 1F, G and H). We also observed a reduction in 
low-level expression of IL-17A by ILC in the absence of Vitamin A, albeit to a lesser 
extent than IL-22 (fig. S1A and B). The expansion in ILC2 was associated with 
significant increase in frequencies and total number of IL-13 expressing ILC (Fig. 1F 
and G). In VAI Rag1–/– mice, ILC derived IL-13 was also dramatically increased 
compared to control mice suggesting that changes in ILC subsets occur independently 
of the adaptive immune system (Fig. 1F and H). Coinciding with increased IL-13 
production ILC also expressed higher levels of IL-5 (fig. S1C and D).  Further, ILC3 
isolated from VAI Rag1–/– mice displayed reduced expression levels of the transcription 
factor RORγt compared to control mice (fig. S1E).  Although the proportions of ILC2 and 
ILC3 were severely altered in both VAI WT and Rag1–/– mice, the absolute number of 
total gut resident ILC remained unchanged in the absence of Vitamin A (fig. S1F and 
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G). This suggests that vitamin A differentially controls the homeostasis of ILC subsets 
but not the overall ILC accumulation in tissue. In addition, our results point to vitamin A 
as the dominant factor mediating the tissue specific accumulation of ILC3 in the GI tract. 
Together these data reveal, in addition to the previously described role of Vitamin A in 
promoting Th17 and Th1 responses21, 43, a novel function for vitamin A in controlling the 
composition of the intestinal ILC compartment.  
Because Vitamin A insufficiency achieved via dietary restriction may be associated with 
additional defects such as altered tissue development and changes in the flora 
composition43, 142, we acutely inhibited RA signaling by treating mice with the pan-retinoic 
acid receptor inhibitor BMS493 (RAi) for 8 days98. Blockade of RA signaling resulted in 
reduced frequencies and absolute numbers of ILC3 and inversely, a significant increase 
of ILC2 in both WT and Rag1–/– mice (Fig. 1I and fig. S2A, B and E).  Additionally, the 
frequency and number of IL-22 producing ILC was reduced while the overall abundance 
of ILC producing IL-13 was significantly increased following RAi treatment in both WT 
and Rag1–/– mice (Fig. 1J and fig. S2C, D and F). Thus, impaired RA signaling inhibits 
ILC3 while promoting ILC2 numbers and cytokine production. These results identify RA 
as a dominant mediator responsible for controlling the intestinal ILC compartment. 
We further assessed if altered ILC homeostasis induced by vitamin A insufficiency was 
reversible upon RA supplementation. Remarkably, treatment of VAI Rag1–/– mice with 
RA for 12 days was sufficient to restore ILC3 frequencies and numbers to levels found in 
control mice and to significantly decrease the frequencies and numbers of ILC2 (Fig. 2A 
upper panel and B). Moreover, expression of IL-22 from intestinal ILC was significantly 
increased upon RA delivery in vivo, whereas ILC expression of IL-13 was repressed 
(Fig. 2A lower panel and C). RA treatment of VAI mice, also restored RORγt 
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expression in ILC3 to levels found in control mice (Fig. 2D). Notably, such RA 
dependent RORgt expression was cell intrinsic since blockade of RA signaling in culture 
of highly purified ILC3 was associated with reduced RORγt expression from purified ILC3 
(Fig. 2E and fig. S3A and B). To investigate if the reciprocal accumulation of intestinal 
ILC subsets was a result of alterations in their proliferative potential we assessed ILC 
subsets for the expression of the cell cycle protein Ki67. Indeed, VAI Rag1–/– mice 
displayed significantly lower frequencies of Ki67 expressing ILC3 in comparison to 
control mice, while the amount of Ki67 expressing ILC2 was greatly increased (Fig. 2F). 
Conversely, addition of RA reversed the proliferative potential of the two ILC subsets to 
frequencies observed in control mice (Fig. 2F). A similar increase in ILC2 and decrease 
in ILC3 proliferation was observed in Rag1–/– mice treated with RAi for 8 days (Fig. 2G). 
These results support the idea that RA acts as a switch to control a proliferative balance 
between the two intestinal ILC subsets and demonstrates that intestinal ILC populations 
respond dynamically to nutritional cues. 
To assess the potential role of RA in ILC development, we sort purified ILC2 progenitors 
(ILC2P), a population of GATA3 expressing cells residing in the bone marrow, which 
were shown to give rise to ILC259, 62, 143. In culture containing low amounts of serum 
associated RA, ILC2P develop into Thy1.2 expressing mature ILC2 able to produce IL-
13 (Fig 2H). Increased concentrations of RA in these culture conditions impaired ILC2 
development as assessed by significant decrease in the absolute number of GATA3+ 
Thy1.2+ cells and IL-13 production compared to the low-dose of RA normally present in 
culture media (Fig. 2H). Conversely, inhibition of RA signaling resulted in substantially 
increased numbers of GATA3+Thy1.2+ cells and a dramatic increase in IL-13 production 
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(Fig. 2H). Thus, these results reveal a cell intrinsic suppressive role of RA on ILC2 
development and demonstrate that RA has the capacity to act directly on the ILC2P. 
Common lymphoid progenitors (CLP) can give rise to both ILC2 and ILC3 subsets in the 
intestine 144, 145. To further explore how RA signaling was able to influence the 
development of ILC in vivo, we transferred common lymphoid progenitors (CLP) and 
followed the de novo generation of ILC in mice known to lack ILC (Rag2–/–gc–/– mice)135. 
These recipient mice were treated with RA, RAi or vehicle control. As previously 
described144, two weeks after transfer in control mice, CLP gave rise to both ILC2 and 
ILC3 that accumulate in the GI tract (Fig. 2I and J). However, when RA levels were 
increased upon exogenous delivery of RA we observed a dominant accumulation of 
ILC3 in the intestinal mucosa (Fig. 2I and J). The opposite effect was observed with in 
vivo inhibition of RA signaling which dramatically altered the distribution of the two 
populations in favor of ILC2  (Fig. 2I and J). All together, our results in vivo and in vitro 
all support the idea that the control of ILC by RA is cell intrinsic and that RA levels 
differentially dictate the size and function of ILC populations. Our results also suggest 
that RA controls ILC3 by promoting various aspects of their overall fitness, cytokine 
production and proliferation. Thus, RA actively limits the amount of ILC2 in the intestine 
by controlling their accumulation while actively promoting the ILC3 subset. 
Vitamin A deficiency results in susceptibility to attaching/effacing diarrheal 
pathogen 
	  
A corollary of our findings is that differential levels of vitamin A could promote different 
classes of barrier immunity with physiological levels of Vitamin A associated with 
adaptive Th17 and ILC3 responses and reduced levels of Vitamin A with enhanced 
innate type 2 immunity. To address this possibility we assessed the capacity of VAI mice 
	  
	  
45	  
to develop an IL-22 dependent immunity to intestinal pathogens. Immunity to Citrobacter 
rodentium is largely dependent on the expression of IL-22 in both WT and Rag1–/– 
mice114, 132. Strikingly, we found that in WT mice, vitamin A insufficiency led to enhanced 
susceptibility to C. rodentium infection and increased pathology compared to control 
mice as assessed by shortened colon length and increased weight loss (fig. S4A and 
B). Similarly, WT mice treated with RAi and infected with C. rodentium showed 
increased weight loss and decreased colon length indicative of enhanced pathology (fig. 
S4C and D). These results highlight that in accordance with defects in both adaptive 
Th17 as well as innate ILC3 responses the absence of vitamin A renders mice more 
susceptible to gastrointestinal infections.  To further dissect the effect of RA signaling on 
ILC3 mediated protective immunity we utilized Rag1–/– mice in which ILC are the 
dominant source of IL-2271. Mice were pre-treated with RAi or vehicle for 5 days and 
infected with C. rodentium. Strikingly, while control mice displayed no significant weight 
loss, mice treated with RAi lost a significant amount of weight during the course of the 
infection associated with decreased colon length and enhanced pathology resulting in 
increased mortality (Fig. 3A, B and C). In addition, frequencies and numbers of ILC3 in 
infected mice were reduced and ILC3 isolated from RAi treated mice showed decreased 
expression of RORγ t coinciding with reduced expression of ILC derived IL-22 (Fig. 3D, E 
and F). Exogenous delivery of IL-22 to VAI mice protected mice from severe gut 
pathology and weight loss demonstrating that IL-22 was sufficient to prevent severe 
disease in vitamin A insufficiency (Fig. 3G and H). Thus, our data propose a yet 
unappreciated connection between Vitamin A and ILC3 protective function. Together 
with the role of vitamin A in the control of Th1746 responses, these results provide an 
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explanation for the profound susceptibility to gastrointestinal infections observed in 
children suffering from vitamin A deficiency.  
 
Vitamin A deficiency promotes innate ILC mediated immunity to helminth 
infection 
	  
The reciprocal regulation of ILC fate implies that type 2 immunity might be 
paradoxically augmented under Vitamin A insufficient settings. In support of this 
hypothesis, a previous report showed that withdrawal of vitamin A was associated with 
enhanced mucus production43. To assess if this effect was directly dependent on the 
increased frequency and function of ILC2, we explored the intestinal structure of mice 
devoid of T cells. Under these settings, IL-13 production was almost entirely ILC2 
derived (fig.  S5A). Goblet cells play a central role in barrier protection by the secretion 
of mucus and antimicrobial peptides146. Consistent with increased ILC2 observed in the 
absence of Vitamin A, VAI Rag1–/– mice displayed significant goblet cell hyperplasia and 
increased goblet cell associated expression of the RELM-b gene, retnlb (Fig. 4A, B and 
C). Goblet cell hyperplasia in absence of Vitamin A was largely dependent upon IL-13, 
since treating mice with a neutralizing anti-IL13 antibody significantly decreased the 
amount of goblet cells per villi in the small intestine of VAI Rag1–/– mice and reduced 
RELM-b expression to control levels (Fig. 4A, B and C). Thus, we identify augmented 
ILC2 derived IL-13 expression as the likely factor underlying goblet cell hyperplasia 
observed in the absence of Vitamin A. This finding is in direct support of our hypothesis 
that differential levels of vitamin A promote different classes of barrier immunity and that 
reduced levels of Vitamin A are associated with enhanced innate type 2 immunity.  
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To test this hypothesis, we assessed the capacity of VAI mice to develop an IL-13 
dependent immunity to chronic intestinal helminth infections. Immunity to Trichuris muris 
is critically dependent on IL-13 production in the context of a type 2 response65. We 
utilized a model of low dose infection in which the host normally fails to clear the worm65. 
Notably, we found that VAI WT mice infected with a low dose of Trichuris muris harbored 
significantly lower worm burden as compared to control mice (Fig. 4D). Further, at 13 
days post infection, the proportion of ILC3 and also ILC derived IL-22 expression were 
impaired in the cecum of VAI mice (Fig. 4E and F).  In contrast the numbers of both 
ILC2 and Th2 cells were significantly increased in VAI mice compared to control mice 
(Fig. 4E and F). Importantly, in this setting, the majority of IL-13 production was ILC 
derived (Fig. 4E and G and fig. S6A). Further, the dominant capacity of ILC2 to produce 
IL-13 was sustained in the absence of Vitamin A and Th2 cells showed increased IL-13 
production in VAI mice in comparison to control mice (Fig. 4E and G and fig. S6A). We 
next assessed if acute blockade of RA signaling could lead to augmented type 2 
immunity. Notably, as early as 6 days post infection, ILC2 responses were already 
heightened in mice treated with RAi as revealed by increased numbers of Ki67 
expressing ILC2 compared to vehicle treated mice (Fig. 4H). In addition, at 12 days post 
infection, in agreement with results obtained in VAI mice, mice treated with RAi had both 
increased numbers of ILC2 and increased IL-13 expression from ILC and T cells (Fig. 4I, 
J and K and fig. S6B). This response resulted in enhanced worm expulsion compared 
to control mice (Fig. 4L). Thus, our results demonstrate that in contrast to acute bacterial 
infection, Vitamin A insufficiency leads to augmented control of helminth infection via the 
promotion of type 2 immunity associated with ILC2 and Th2 cells. 
Discussion:  innate immune compensation during vitamin A deficiency   
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Altogether our study identifies micronutrients as a novel cue guiding ILC fate and 
demonstrates that intestinal ILC populations respond dynamically to dietary intake. 
Further, our findings reveal that via its profound impact on ILC and T cells, vitamin A 
plays a central role in dictating the class of barrier immunity. Contrary to the current 
paradigm our present work reveals that malnutrition is not associated with global 
immunosuppression but rather can selectively activate a distinct arm of barrier immunity. 
Notably, our results propose that in settings of transient malnutrition, augmented type 2 
immunity from both ILC2 and Th2 cells may represent an important strategy to control 
exposure to ongoing mucosal challenges. Indeed, type 2 immunity and in particular IL-13 
is associated with tissue repair, increased mucus production and epithelial responses all 
aimed at reinforcing barrier integrity66, 147. Further, type 2 responses are clearly beneficial 
in the context of exposure to worms that have been partners throughout human 
evolution and still represent the major form of parasitic infection worldwide. In summary, 
our work proposes that vitamin A and its metabolite RA, functions as a dietary sensor for 
the nutritional state of the host. In settings of malnutrition, a rapid switch to type 2 barrier 
immunity imposed by limiting Vitamin A availability may represent a powerful adaptation 
of the immune system to transiently promote host survival in the face of dominant barrier 
exposures. Since parasites compete with the host for nutritional resources it is intriguing 
to speculate that in times of insufficient dietary uptake, reinforcement of anti-helminth 
immunity can provide a substantial advantage to the host. Such a tactic may leave the 
host vulnerable to potential encounters with acute pathogens but could provide a 
survival strategy to temporarily reduce the pressure from its constitutive evolutionary 
partners, worms and commensals in settings of nutritional deprivation.   
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Figure 12:  
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Figure 12: ILC3 are enriched in the GI tract and depend on retinoic acid.  A) 
Flow cytometric analysis of cells isolated from small intestinal lamina propria (gut), 
lung and skin of naïve C57Bl/6 mice. Upper panel represents live CD45+ cells 
stained with Thy1.2 and lineage (lin) markers (NK1.1, TCRβ, TCRγδ, CD11b, 
CD11c, CD4, CD8α, CD8β, CD19, GR-1, DX5, Ter119). Lower panel displays 
cells gated on Lin- and Thy1.2 expression (ILC), stained for RORγt (ILC3) and 
GATA3 (ILC2).  B) Frequencies of ILC2 and ILC3 in gut, lung and skin. C) Cells 
were isolated from the small intestine lamina propria (SiLP) from control (Ctrl) or 
vitamin A insufficient (VAI) WT or Rag1–/– mice, gated on Lin–, Thy1.2+ cells and 
analyzed for GATA3 and RORγt expression. D-E) Total numbers of ILC3 (RORγt+) 
and ILC2 (GATA3+) cells in the SiLP of WT and Rag1–/– mice. F) Intracellular IL-13 
and IL-22 expression in Lin- Thy1.2+ cells following stimulation with PMA and 
ionomycin and G-H) Total numbers of IL-22 and IL-13 producing ILC in the SiLP. I) 
Lin- Thy1.2+ cells from the SiLP of Rag1–/– mice treated with vehicle control (Veh) 
or retinoic acid receptor inhibitor (RAi) for 8 days, were stained for GATA3 and 
RORγt expression. J) Intracellular IL-13 and IL-22 expression in Lin- Thy1.2+ cells 
following stimulation with PMA and ionomycin. Results are representative of at 
least three independent experiments with 3-5 mice in each experimental group. All 
graphs display means ±SEM. 
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Figure 13: 
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Figure 13: Retinoic Acid dynamically regulates developmental balance 
between ILC subsets Cells were isolated from the small intestine lamina propria 
(SiLP) of control (Ctrl), vitamin A insufficient (VAI) or VAI treated with all-trans 
retinoic acid every three days for 12 days (VAI + RA) of Rag1–/– mice.  A) GATA3 
and RORγt expression in Lin–, Thy1.2+ cells (upper panel). Intracellular IL-13 and IL-
22 expression in Lin- Thy1.2+ cells following stimulation with PMA and ionomycin 
(lower panel). B) Total numbers of ILC3 (RORγt+) and ILC2 (GATA3+) cells in SiLP 
and C) total numbers of IL-22 and IL-13 producing ILC in the SiLP. D) RORγt 
expression in ILC3 from SiLP of Ctrl, VAI or VAI + RA Rag1–/– mice. E) RORγt+ 
expression levels from sort purified ILC3 cultured in vitro for seven days in the 
presence of either exogenous RA (RA) or retinoic acid inhibitor (RAI) and gated on 
live, CD45+, Lin–, Thy1.2+ and RORγt+ cells (left panel) and mean fluorescent 
intensity of RORγt expression on ILC3 cultured in medium with vehicle control (Veh), 
RA (RA) or RAI (RAi) (right panel). F) Frequencies of Ki67 expression in ILC3 and 
ILC2 isolated from SiLp of Ctrl, VAI or VAI +RA Rag1–/– mice.  G) SiLP cells of Rag1–
/– mice treated with retinoic acid receptor inhibitor (RAi) or vehicle control (Veh) for 8 
days were stained for intracellular Ki67 and gated on Lin–, Thy1.2+ RORγt+ cells 
(ILC3; upper panel) cells and GATA3+ cells (ILC2; lower panel). H) ILC2 progenitors 
(ILC2P) were sort purified from bone marrow and cultured in vitro with IL-7 and SCF 
in the presence of vehicle control (Veh), RA and RAi (RAi). After 7 days of culture, 
total numbers of Thy1.2+ GATA3+ cells were analyzed (left panel) and IL-13 
production in the culture supernatant was measured (right panel).  I) 100,000 
CD45.1+ common lymphoid progenitors (CLP) were transferred into congenic 
CD45.2+ Rag2–/–/γc–/– mice and treated either with vehicle (Veh), RA or RAi.  14 Days 
after transfer, SiLP cells were isolated, stained for GATA3 and RORγt and gated on 
CD45.1+, Lin– and Thy1.2+ cells. J) Quantification of relative proportion of ILC3 and 
ILC2 in recipient mice.  Data are representative of at least three independent 
experiments with 3-4 mice in each experimental group (A-D, F-G) or at least two 
independent experiments with 3 experimental groups of cells isolated from 2 mice 
each (E and H). (I and J) display a compilation of three independent experiments.  
All graphs display means ±SEM. 
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Figure 14 
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Figure 14: Vitamin A deficiency results in impaired immunity to bacterial 
infections  Rag1–/– mice given either vehicle control (Veh) or retinoic acid receptor 
inhibitor (RAi) were infected with C. rodentium. A) Percentile change of original body 
weight and frequency of surviving animals. B) Colon length and C) representative H&E 
histological sections of colonic tissue analyzed 10 days post-infection. D) Large 
intestine lamina propria (LiLp) cells isolated from vehicle (Veh) or RAI (RAI) treated 
Rag1–/– mice 10 days after infection with C. rodentium, gated on Lin–, Thy1.2+ cells and 
analyzed for GATA3 and RORγt expression (upper panel). Intracellular IL-13 and IL-22 
expression in Lin- Thy1.2+ cells following stimulation with PMA and ionomycin (lower 
panel). E) Total numbers of RORγt expressing ILC and total numbers of IL-22 
producing ILC per colon. F) RORγt expression levels in ILC3 from vehicle control and 
RAI treated mice. G) Percentile change of original body weight of control (Ctrl), vitamin 
A insufficient (VAI) or VAI Rag1–/– mice treated with IL-22 (VAI+IL-22) infected with C. 
rodentium. H) Colon length analyzed 13 days post-infection.  Data represent at least 
three (A-F) or two (G and H) independent experiments with 3-4 mice in each 
experimental group.  All graphs display means ±SEM. 
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Figure 15 
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Figure 15: Vitamin A deficiency results in increased immunity to helminth 
infections A). Small intestine histologic sections of control (Ctrl), vitamin A 
insufficient (VAI) or VAI Rag1–/– mice treated with anti-IL13 antibody (VAI+αIL13) 
stained with PAS to visualize goblet cells. B) Total numbers of PAS-positive goblet 
cells per crypt and C) Retnlb (Relm-β) gene expression in the small intestine of Ctrl, 
VAI or VAI+αIL13 Rag1–/– mice. D) Total number of worms in the cecum 12 days 
after infection. E) Cells were isolated from the lamina propria of the cecum of control 
(Ctrl) or VAI WT mice 13 days after oral infection with T. muris. Cells were gated on 
Lin–, Thy1.2+ cells and analyzed for GATA3 and RORγt expression (upper panel). 
Intracellular IL-13 and IL-22 expression in Lin- Thy1.2+ cells following stimulation with 
PMA and ionomycin (lower panel). F) Total numbers of ILC2 (GATA3+) and Th2 
(GATA3+ Foxp3– CD4+ TCRβ+) cells and G) total numbers of IL-13 producing ILC 
CD4+ T cells in the in the cecum. H) Total numbers of Ki67 expressing ILC2 isolated 
from the cecum of vehicle (Veh) or retinoic acid inhibitor (RAI) treated WT mice 6 
days after infection with T. muris. I) Lamina propria (LiLp) cells were isolated form the 
cecum of vehicle or RAI treated WT mice 12 days after oral infection with T. muris. 
Cells were gated on Lin–, Thy1.2+ cells and analyzed for GATA3 and RORγt 
expression (upper panel). Intracellular IL-13 and IL-22 expression in Lin- Thy1.2+ 
cells following stimulation with PMA and ionomycin (lower panel). J) Total numbers 
of ILC2 (GATA3+) and Th2 (GATA3+ Foxp3– CD4+ TCRβ+) cells and K) total numbers 
of IL-13 producing ILC CD4+ T cells in the in the cecum. L) Total number of worms in 
the cecum 12 days after infection. All graphs display means ±SEM. 
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Figure Supplemental 1 
	  
Figure S1:  ILC number and function in vitamin A insufficiency. Cells were 
isolated from the small intestine lamina propria (SiLP) from control (Ctrl) or vitamin A 
insufficient (VAI) WT and Rag1–/– mice. A) Intracellular IL-17A and IL-22 expression 
in Lin- Thy1.2+ cells following stimulation with PMA and ionomycin in WT mice B) 
frequencies of IL-17 expressing ILC in the small intestine. (Graphs mean ±SEM). C) 
Intracellular IL-13 and IL-5 expression from Lin- Thy1.2+ cells following stimulation 
with PMA and ionomycin in WT mice D) frequencies of IL-13 and IL-5 expressing ILC 
in the small intestine. E) RORγt expression in ILC3 from Ctrl and VAI Rag1–/– mice. 
F) Total numbers of ILC in WT and G) Rag1–/– VAI mice. 
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ILC number and function in vitamin A insufficiency. Cells were isolated from the small 
intestine lamina propria (SiLP) from control (Ctrl) or vitamin A insufficient (VAI) WT and 
Rag1–/–  mice.  ) Intracellular IL-17A and IL-22 expression in Lin- Thy1.2+ cells following 
stimulation with PMA and ion mycin in WT mice  B) frequencies of IL-17 expressing ILC in 
the small intestine.  (Graphs mean ±SEM).  C) Intracellular  IL-13 and IL-5 expression from 
Lin- Thy1.2+ cells following stimulation with PMA and ionomycind in WT mice D) frequen-
cies of IL-13 and IL-5 expressing ILC in the small intestine.  E) RORќt expression in ILC3 
from Ctrl and VAI Rag1–/– mice. F) Total numbers of ILC in WT and G) Rag1–/– VAI mice.
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Supplemental Figure 2 
	  
Figure S2: ILC number and function in the absence of RA signaling. A) Cells 
isolated from the small intestine lamina propria (SiLP) of WT mice treated with retinoic 
acid receptor inhibitor (RAi) or vehicle control (Veh) for 8 days were stained for 
GATA3 and RORγt and gated on Lin– and Thy1.2+ cells. B) Total numbers of ILC3 
(RORγt+) and ILC2 (GATA3+) cells in Veh or RAi mice. C) Flow cytometry of SiLP cells 
stimulated with PMA and ionomicin for 2h, gated on Lin- Thy1.2+ cells and analyzed 
for intracellular IL-13 and IL-22 expression and D) total numbers of IL-22 and IL-13 
producing ILC in the small intestine. E) Total number of ILC3 and ILC2 isolated from 
the small intestine lamina propria (SiLP) of Rag1–/– mice treated with retinoic acid 
receptor inhibitor (RAi) or vehicle control (Veh) for 8 days F) Total numbers of IL-22 
and IL-13 producing ILC in the small intestine. Data represent at least two 
independent experiments with 3-4 mice in each experimental group (Graphs display 
mean ±SEM). 
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Supplemental Figure 3 
	  
Figure S3: Sorting strategy for isolation of ILC populations from the small 
intestine lamina propria (SiLP) of naïve C57/Bl6 mice. A) SiLP cells were 
stained with lineage markers (NK1.1, TCRβ, TCRγδ, CD11b, CD11c, CD4, CD8a, 
CD8b, CD19, GR-1, DX5, Ter119) and Thy1.2 and gated on live and CD45+ cells. 
ILC2 were sorted as Thy1+, Lineage-, KLRG1+ and ILC3 were sorted as Thy1hi, 
KLRG-, and IL7R+ yeilding greater than 99% of cells expressing Gata-3 and Rorgt 
respectively. B) Post-sort purity measurements indicating greater than 99% purity 
of sorted populations. 
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Supplemental Figure 4 
	  
Figure S4: Citrobacter rodentium infection induced pathology in the absence 
of viatmin A and RA signaling. A) Percentile change of original body weight and 
B) colon length of vitamin A insufficient (VAI) and control (Ctrl) C57Bl/6 mice 
infected with C. rodentium at Day 9. C) Change of body weight and D) colon length 
in C57Bl/6 mice treated with retinoic acid receptor inhibitor (RAi) or vehicle control 
(Veh) and infected with C. rodentium at Day 15. 
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Supplementary Figure 4 
Citrobacter rodentium infection induced pathology in the absence of viatmin A and 
RA signaling. A)  Percentile change of original body weight and B) colon length of vitamin 
A insufficient (VAI) and control (Ctrl) C57Bl/6 mice i fected with C. rodentium at Day 9. C) 
Change of body weight and D) colon length in C57Bl/6 mice treated with retinoic acid 
receptor inhibitor (RAi) or vehicle control (Veh) and infected with C. rodentium at Day 15. 
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Supplemental Figure 5 
	  
Figure	  S5:	  ILC are the dominant source of IL-13 in VAI RAG1–/– mice. A) Cells 
isolated from the small intestine lamina propria (SiLP) from control (Ctrl), vitamin A 
insufficient (VAI) RAG1–/– mice stim- ulated with PMA and ionomicin for 2h, gated 
on CD45+ cells, stained for lineage markers and intracellular IL-13. Data 
represents three independent experiments. 
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ILC are the dominant source of IL-13 in VAI RAG1–/– mice.  A) Cells isolated from the small 
intestine lamina propria (SiLP) from control (Ctrl), vitamin A insufficient (VAI) RAG1–/– mice stim-
ulated with PMA and ionomicin for 2h, gated on CD45+ cells, stained for  lineage markers and 
intracellular IL-13. Data represents three independent experiments.
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Supplementary Figure 6 
	  
Figure S6:  Cytokine expression from T cells during infection with T. muris. A) 
Lamina propria (LiLp) cells were isolated form the cecum of control (Ctrl) or VAI WT 
mice 13 days after oral infection with T. muris. Cells were gated on CD4+ TCRβ+ cells 
and analyzed for intra- cellular IL-13 and IL-22 expression. B) Intracellular IL-13 and 
IL-22 expression in CD4+ TCRβ+ cells isolated from the cecum of vehicle (Veh) or 
RAI treated WT mice 12 days after infection with T. muris. 
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Cytokine expression from T cells during infection with T. muris. A) Lamina propria 
(LiLp) cells were isolated form the cecum of control (Ctrl) or VAI WT mice 13 days after 
oral infection with T. muris. Cells were gated on CD4+ TCR`
 cells and analyzed for intra-
cellular IL-13 and IL-22 expression. B) Intracellular IL-13 and IL-22 expression in CD4+ 
TCR`
 cells isolated from the cecum of vehicle (Veh) or RAI treated WT mice 12 days 
after infection with T. muris.
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Supplemental Figure 7 
	  
Figure S7: Schematic of ILC response to Vitamin A deprivation 
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CHAPTER 5: UNDERSTANDING THE ROLE OF VITAMIN A AS A 
CRITICAL MEDIATOR OF INNATE INTESTINAL IMMUNITY 
 
Dietary Vitamin A is a dominant regulator of intestinal immunity 
The role of vitamin A in supporting immunity has been an active area of research for 
nearly 85 years, and as early as 1928 the ability of vitamin A to augment immunity to 
infections was appreciated and it was labeled the “anti-infective vitamin”49.   The work 
outlined in the previous chapter offer a potential mechanistic explanation of the profound 
susceptibility of vitamin A deficient children to bacterial diarrheal pathogens23. The 
intestinal immune system contains several layers of redundant defense that coordinate 
to defend against pathogens, many of which are lost during vitamin A deficiency.  IgA 
secreting plasma cells coat luminal bacteria preventing their translocation148 and IL-22, 
critical for defense against attaching/effacing pathogens, comes from both adaptive and 
innate sources 70, 71.   In the vitamin A deficient setting IgA secretion in the gut in lost 
almost entirely35, due to impaired priming, trafficking and survival of mucosal B cells36.   
Secondly, adaptive TH17 cells that secrete IL-22 have impaired differentiation and 
trafficking95, and gamma delta T cells have decreased levels of IL-22 production149 
resulting in a loss of adaptive sources of IL-22 in the gut during vitamin A deficiency.  
The data presented in chapters 3 and chapters 4, in accordance with a recently 
published report 149, find that innate lymphoid cell derived IL-22 is also reduced.  Thus, 
the profound susceptibility to diarrheal pathogens seen in mice and humans with a lack 
of dietary vitamin A is the result a breakdown in a nearly all mechanisms of protection 
employed by the host during infection with an attaching/effacing diarrheal pathogen.   
  While many aspects of tissue resident innate immunity are lost in the absence of 
retinoic acid signaling, an outstanding question that remained was if there were 
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compensatory mechanisms in place to maintain barrier defense in settings of 
malnutrition.   We present data in chapter 4 demonstrating that withdrawal of vitamin A 
or retinoic acid signaling augments ILC2 function.  Increased levels of IL-13 production 
from the expanded pool of ILC2s results in goblet cell hyperplasia and increased 
protection from low dose helminth infection.  We believe that the data in Chapter 4 
support the idea that increased ILC2 responses in vitamin A deficiency represents a 
powerful adaptation to protect the host.  Helminth infection is a known contributing factor 
to malnutrition and may itself lead to vitamin A difficiency73, 150. It is therefore intriguing to 
speculate that in times of insufficient dietary uptake, reinforcement of anti-helminth 
immunity can provide a substantial advantage to the host.  However, it is unclear 
whether there are untoward consequences of excessive goblet cell hyperplasia in states 
of malnutrition.  It is possible that increased mucus production could inhibit the 
absorptive capacity of the small intestine and would be maladaptive.  Thus, the potential 
pathogenic consequences of ILC2 adaptation to malnutrition warrant further 
investigation.     
Global health perspective for vitamin A supplementation 
Vitamin A supplementation is incredibility effective public health intervention.  How does 
the data presented in the previous chapters integrate with what is known about the 
effectiveness of vitamin A supplementation, particularly in regions with a high burden of 
helminth infection?    It is clearly advantageous for the host to be replete of vitamin A 
stores.  Although our data would support a suppressive role of RA on ILC2 there are 
several points to take into consideration.  First, we have demonstrated that ILC2 function 
is augmented in steady state and low dose infectious settings.   An outstanding question 
is if there are mechanisms in place to overcome the suppressive actions of RA in highly 
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inflammatory settings.  Indeed, we have preliminary data suggesting that while RA may 
limit ILC2 proliferation in a non-inflammatory setting, RA may be required to support IL-
33 and IL-2 dependent inflammatory proliferation of ILC2 via regulation of IL-33 and IL-2 
receptor levels. Thus, in malnutrition, the beneficial functions of ILC2 are likely limited to 
non-inflammatory settings.  Second, Th2 responses are augmented by RA151 and 
vitamin A deficiency limits the ability to mount Th2 responses152, 153.  All together, this 
means that while RA supplementation may inhibit ILC2 response, it will allow for a 
compensatory increase in Th2 function.   All together, our data highlight an important 
mechanism of innate ILC2 compensation during nutrient deprivation, but do not 
contradict the beneficial role of vitamin A supplementation in settings of helminth 
infection.   
Is vitamin A a keystone nutrient required for inflammation? 
 
The immune system imposes a high metabolic cost to the host. Although mounting an 
active inflammatory response can consume large amounts of energy, this relationship is 
difficult to precisely quantify.  Current estimates are that during an acute inflammatory 
reaction the immune system accounts for an 8-14% increase in energy consumption 154.  
Emerging evidence indicates that in order to mount an inflammatory response the 
immune system must actively sense sufficient nutrient status of the host; such as sterols 
and nucleic acids 155, 156, 157.  In addition to sensing the availability of substrates required 
for anabolism, sensing of keystone indicators of nutrient status also appears to play a 
role in governing immune activation158, 159.  A key example of this that leptin, an 
adipokine that regulates appetite and energy expenditure, is required for full T cell 
activation 158, 159.   Thus, it appears that the immune system actively senses the 
	  
	  
67	  
nutritional status of the host to license an immune response.  Given that vitamin A 
deficiency is nearly universally associated with an malnourished state, I propose that the 
Vitamin A metabolite retinoic acid (RA) serves as a key indicator of nutrient status and 
that RA signaling may be a critical checkpoint necessary to license immune cells for 
proliferation and inflammation.  
The sensing of nutritional status by the immune system is relayed mainly via the mTOR 
signaling pathways, with mTOR serving as a bridge between nutrient status and immune 
activation 155, 156, 157.  Therefore, it is possible that the effects of RA signaling are 
dependent on mTOR signaling.  Accordingly, I would predict that mice deficient in either 
mTORC1 (Raptor) or mTORC2 (Rictor) have a similar ILC phenotype to vitamin A 
deficient mice: decreased ILC3 and increased ILC2.  If mTORC deficient mice 
maintained a normal ILC compartment, this would indicate that vitamin A deficiency 
controls ILC homeostasis independent of mTOR signaling.  These experiments would be 
important to further dissect the mechanism of action by which RA controls ILC 
homestatsis.    
Do ILC2 have unique metabolic requirements? 
	  
Survival of the host requires functional immunity in a diversity of nutritional states.  
Aspects of immunity that could function efficiently in settings of malnutrition would be 
advantageous to the host for surviving periods of impaired nutrition.  Thus, I propose that 
the immune responses remaining in vitamin A deficiency may be metabolically distinct 
from those that are vitamin A dependent.  I predict that remaining immunity during 
vitamin A deficiency is specialized for energetic efficiency to provide protective immunity 
with as little energy consumption as possible.    
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Our data, along with that of others, demonstrate that TH17, TH1 and ILC3 responses are 
highly reliant on RA while ILC2 responses are not.  This raises a critical question: is the 
RA-independence of homeostatic ILC2 responses indicative of their unique metabolic 
requirements?  The current paradigm suggests that TH17 and TH1 responses, via 
activation of an mTORC1 and HIF-1a dependent pathway, are more glycolytic and 
anabolic in nature160, 161, 162. Treg and Th2 responses however are less glycolytic and are 
catabolic in nature via activation of an mTORC1 and HIF-1a independent pathway160, 161, 
162.  Given the conserved transcriptional networks between T cells and ILCs, these data 
imply a potential metabolic difference between pathways for IL-22 and IFN-g production 
and pathways for IL-13 and IL-4 production in lymphocytes.  Thus, I predict that ILC3 
would by reliant on glycolysis for IL-22 production while ILC2 would produce IL-13 
independent of glycolysis.  To address this hypothesis, I propose a line of experiments to 
determine to relative dependence of ILC3 and ILC2 on glycolytic and oxidative 
phosphorylation pathways to mount a protective immune response.    
To assess the metabolic requirements for ILC subsets I would use both in vitro and in 
vivo approaches.  First, I would purify ILC2 and ILC3 to determine their relative use of 
glycolysis and oxidative phosphorylation in vitro using a Seahorse extracellular flux 
analyzer.  Given the literature on Th17 cells, ILC3 should rely more on glycolysis and 
have less oxidative phosphorylation.  ILC2 however, should predominately rely on 
oxidative phosphorylation.  By measuring relative metabolic pathway usage coupled with 
cytokine production capacity, one could test the substrate metabolism used for IL-22 
production as compared to IL-13 production.  To further pursue this line of experiments, I 
would test metabolic pathway utilization by ILCs in the presence or absence of RA.   I 
predict that when RA signaling is inhibited there would be less ILC3 mediated glycolysis 
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and consequently less IL-22 production.  Inversely, I predict that when RA signaling is 
inhibited ILC2 utilization of oxidative phosphorylation and production of IL-13 would be 
augmented.   Given the efficiency in ATP generation is greatly decreased with glycolysis 
as compared to oxidative phosphorylation, this hypothesis suggests that innate type 2 
responses occur at a lower metabolic cost than TH17 and ILC3 responses.  All together, 
testing this hypothesis could elucidate potential metabolic differences between 
lymphocyte subsets and could offer a potential explanation for the outgrowth of innate 
type 2 immunity in vitamin A deficiency.    
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Figure 16: 
	  
Figure	  16:	  Schematic	  of	  the	  role	  of	  vitamin	  A	  in	  the	  control	  of	  intestinal	  immunity	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CHAPTER 6: MATERIALS AND METHODS 
 
Mice 
C57BL/6 (WT), Rag1–/– and Rag2–/–γc–/– mice were purchased from Taconic Farms. All 
mice were bred and maintained under pathogen-free conditions at an American 
Association for the Accreditation of Laboratory Animal Care accredited animal facility at 
the NIAID and housed in accordance with the procedures outlined in the Guide for the 
Care and Use of Laboratory Animals under an animal study proposal approved by the 
NIAID Animal Care and Use Committee. All mice were used between 6 and 13 weeks of 
age. 
Diet Studies 
Vitamin A-deficient (TD.10991) and -sufficient (20,000 IU vitamin A/kg, TD.10992) diets 
were purchased from Harlan Teklad Diets. At day 14.5 of gestation, pregnant females 
were administered either vitamin A-deficient or -sufficient diet and maintained on diet 
until weaning of litter. Weanlings were maintained on special diet throughout study.  
Cell isolation from the lamina propria and Flow Cytometry 
Cells from small and large intestinal lamina propria (Lp) were prepared as previously 
described41. Single-cell suspensions were stained with CD16/32 (eBioscience) and with 
fluorochrome-conjugated antibodies against any combination of the following surface 
antigens: CD4, CD8α, CD11b, CD11c, DX5, CD49b, TCR-β, TCR-γδ, CD19, Ter119, 
NK1.1, Gr-1 and Thy1.2. Prior to fixation Live/Dead Fixable Blue Cell Stain Kit 
(Invitrogen) was used to exclude dead cells. For examination of transcription factors and 
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cellular proliferation, cells were subsequently treated with the FOXP3 staining kit 
(eBioscience) in accordance with the manufacturer's instructions and stained for 20 min 
at room temperature with fluorochrome-conjugated antibodies against the following: 
RORγt, GATA3 and Ki67. 
Intracellular cytokine staining 
Isolated cells from lamina propria were stimulated for 2 h with phorbol 12- myristate 13-
acetate (PMA) (50ng/ml) and ionomycin (2.5µg/ml) in the presence of Brefeldin A 
(1µg/ml)	  (GolgiPlug, BD Biosciences). 
Cell isolation from the lung and skin 
Tissues were diced followed by digestion with 0.25mg/ml liberase TL (Roche) at 37˚C for 
45 min (lung) or liberase and 1mg/ml DNase at 37˚C for 1h 15min (skin). Isolated lung 
cells were further purified using a 37.5% Percoll gradient followed by lysis of red blood 
cells with ACK. 
Fluorescence-activated cell sorting and in vitro culture of ILC and ILC2P  
ILC3 were sorted by flow cytometry from small intestine Lp cells from WT and VAI mice 
based on the absence of lineage markers (CD4, CD8α, CD11b, CD11c, DX5, CD49b, 
TCR-β, TCR-γδ, CD19, Ter119, NK1.1 and Gr-1) but expression of Thy1.2 and IL-7R.  
ILC2 were sorted as lineage negative, Thy1.2+, KLRG1+. ILC2 progenitors (ILC2P) were 
sorted from the bone marrow of Rag1–/– mice by the absence of lineage makers and c-
Kit, but expression of IL-7R, CD25 and high levels of Sca-159, 62, 143. RPMI 1640 
supplemented with 10% FBS, penicillin, streptomycin, HEPES, glutamine, nonessential 
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amino acids, and 50 mM of β-mercaptoethanol (Complete Media) was used for in vitro 
culture. ILC3 or ILC2P were cultured in the presence of IL-7 (10ng/ml) and SCF 
(10ng/ml) in the presence or absence of 1 µM all-trans RA (Sigma-Aldrich) or 1.8 µM RA 
inhibitor BMS 493 (Tocris, UK) for 7 days. IL-13 cytokine expression in the cell free 
supernatant was assessed using a bead based cytokine detection assay (FlowCytomix, 
eBioscience) and was adjusted to the plated density of 5x103 cells in 50 µl culture 
volume. 
Real time PCR  
Tissues were homogenized using metal beads (Precellys). RNA was extracted using 
RNAeasy mini kit (Qiagen) and reverse transcribed with Omniscript (Qiagen) according 
to the manufacturer’s intructions. The cDNA served as template for the amplification of 
genes of interest and the housekeeping gene (b-actin) by real-time PCR using SYBR 
green. Target gene expression was calculated using the comparative method for relative 
quantification upon normalisation to b-actin gene expression. Primer sequences: (actb: 
5’- AAGTGTGACGTTGACATCCGTAA-3’ and 5’-TGCCTGGGTACATGGTGGTA-3’; 
retnlb: 5’-ATGGGTGTCACTGGATGTGCTT-3’ and 5’-AGCACTGGCAGTGGCAAGTA-
3’) 
In Vivo RA Reconstitution 
A total of 250 μg of all-trans-RA (Sigma Aldrich) in 30 μl of biotechnology performance 
certified DMSO (Sigma Aldrich) was administered intraperitoneally to vitamin A-
insufficient mice every other day for 12 days. Mice not receiving RA received DMSO 
vehicle.  
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In Vivo retinoic acid inhibitor (BMS493) treatment 
A total of 220μg of the pan retinoic acid receptor inverse agonist BMS 493 (R&D) 
resuspended in 30 μl of biotechnology performance certified DMSO (Sigma Aldrich) was 
administered intraperitoneally to Rag1–/– mice every day for 8 days as previously 
described98. Control mice received DMSO only.  In some experiments Rag1–/– mice 
were treated with RAi for 5 days followed by infection with C.rodentium. Injection of RAi 
or DMSO continued until the mice were sacrificed but not longer than 14 days of total 
treatment. 
Vaccine Protocol 
For vaccination, mice were orally inoculated with an isotonic bicarbonate buffer. Ten 
minutes later, mice were gavaged with a mixture of 1 mg of OVA and 20 μg of the 
doublemutant form of E. coli LT (R192G/L211A) prepared in the same buffer. 
LT(R129G/L211A) was kindly provided by J. Clements. For experiments, mice were 
vaccinated once per week and immune responses were assessed 1 week after 
challenge on Day 14. 
Oral antigen administration/Treg conversion Assay 
T lymphocytes were extracted from the secondary LNs (excluding the spleen) of 
RAG1−/− OT-II Tg mice (Ly5.1) and adoptively transferred into recipient mice. Each 
mouse received 106 cells. Recipient mice were received a 1.5% OVA solution dissolved 
in drinking water that was replaced every 48 h (grade V; Sigma-Aldrich) for 6 
consecutive days. On day 7 cells were isolated from the hosts and Foxp3 expression 
was assessed in transferred cells. 
	  
	  
75	  
Aldefluor Assay 
Cell suspensions were surface stained (1×106 cells/ml) and incubated for 30 minutes at 
37°C in ALDEFLUOR assay buffer containing activated ALDEFLUOR per manufactures 
recommendation (Stem Cell Technologies). Cells were analyzed via flow cytometry. 
Background ALDEFLOUR staining was less than 0.5% in the presence of the RALDH 
inhibitor diethylaminobenzaldehyde (DEAB). 
Infection with Citrobacter rodentium  
For Citrobacter rodentium infections (formerly Citrobacter freundii, biotype 4280) strain 
DBS100 (provided by David Artis, University of Pennsylvania, Philadelphia, 
Pennsylvania, USA) was prepared by selecting a single colony and culturing in LB broth 
for 8 hours. Mice pre-treated for 5 days with vehicle control or RAi were inoculated with 
approximately 1 × 1010 CFU in 200 µL of PBS via oral gavage. In some case VAI mice 
were treated with 400ng of recombinant mouse IL-22 (rmIL-22, Biolegend) every day for 
4 days starting 2 days before infection. Treatment with rmIL-22 continued every other 
day from day 2 after infection until mice were sacrificed. 
Infection with Trichuris muris  
Mice were infected with 25-30 embryonated Trichuris muris eggs (a gift from Joseph 
Urban, USDA, Beltsville, MD, USA) on day 0 by oral gavage. 12-13 days later infected 
mice were sacrificed and their worm burden was assessed in the cecal epithelial cell 
layer. In some case C57Bl/6 WT mice were simultaneous treated with vehicle or RAi 
every day starting upon infections with T. muris. 
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Goblet cells scoring in the small intestine  
Sections of the small intestine of control mice or VAI mice were stained with periodic 
acid-schiff (PAS). 5-10 villi per slide were assessed for PAS positive goblet cells. A total 
of 2 slides distributed over 3 randomly selected areas were counted. In some cases VAI 
mice were treated with 500ng of anti-IL-13 antibody163 (a gift from Centocor Inc.) every 5 
days for up to two weeks. 
Statistical analysis.  
A two-tailed Student’s t-test was used for all statistical analysis, * p≤ 0.05, **p ≤ 0.005, 
*** p≤0.0005. 
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